<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><?origin nihpa?><?iso-abbr Nat. Immunol.?><?submitter-system nihms?><?submitter-canonical-name Nature Publishing Group?><?submitter-canonical-id NATURE-STRUCTUR?><?submitter-userid 1045?><?submitter-authority publisher?><?submitter-login nature-structure?><?submitter-name Nature Publishing Group (obsolete)?><?domain nihpa?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100941354</journal-id><journal-id journal-id-type="pubmed-jr-id">21750</journal-id><journal-id journal-id-type="nlm-ta">Nat Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Nat. Immunol.</journal-id><journal-title-group><journal-title>Nature immunology</journal-title></journal-title-group><issn pub-type="ppub">1529-2908</issn><issn pub-type="epub">1529-2916</issn></journal-meta><article-meta><article-id pub-id-type="pmcid">4270846</article-id><article-id pub-id-type="pmid">25419629</article-id><article-id pub-id-type="doi">10.1038/ni.3043</article-id><article-id pub-id-type="manuscript">nihpa638367</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The TCR&#x02019;s sensitivity to self-peptide&#x02013;MHC dictates the ability of
na&#x000ef;ve CD8<sup>+</sup> T cells to respond to foreign
antigens</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fulton</surname><given-names>Ross B.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hamilton</surname><given-names>Sara E.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Xing</surname><given-names>Yan</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Best</surname><given-names>J. Adam</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Goldrath</surname><given-names>Ananda W.</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hogquist</surname><given-names>Kristin A.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jameson</surname><given-names>Stephen C.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Laboratory Medicine and Pathology, Center for Immunology,
University of Minnesota Medical School, Minneapolis, MN, 55414, USA</aff><aff id="A2"><label>2</label>Division of Biological Sciences, University of California San Diego, La
Jolla, California, USA</aff><author-notes><corresp id="FN1">Correspondence should be addressed to S.C.J.
(<email>james024@umn.edu</email>), phone: 612-625-1496, fax: 612-625-2199</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>29</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2014</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>7</month><year>2015</year></pub-date><volume>16</volume><issue>1</issue><fpage>107</fpage><lpage>117</lpage><!--elocation-id from pubmed: 10.1038/ni.3043--><permissions><license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms"><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p></license></permissions><abstract><p id="P1">The strength of self-peptide&#x02013;major histocompatibility complex (MHC)
recognition dictates na&#x000ef;ve CD8<sup>+</sup> T cell homeostasis, but its
effect on foreign antigen reactivity is controversial. As CD5 expression correlates with
self-recognition, we studied CD5<sup>lo</sup> and CD5<sup>hi</sup> na&#x000ef;ve
CD8<sup>+</sup> T cells. Gene expression characteristics suggested
CD5<sup>hi</sup> cells were better poised for reactivity and differentiation compared to
the CD5<sup>lo</sup> population, and we found that the CD5<sup>hi</sup> pool exhibited
more efficient clonal recruitment and expansion, as well as enhanced reactivity to
inflammatory cues, during recognition of foreign antigen. Yet foreign peptide&#x02013;MHC
recognition was similar for both subsets. Thus, CD8<sup>+</sup> T cells with
higher self-reactivity dominate the immune response against foreign antigens, with
implications for T cell repertoire diversity and autoimmunity.</p></abstract></article-meta></front><body><p id="P2">The nature of the TCR interaction with foreign peptide&#x02013;MHC (pMHC) complexes
dictates the response magnitude and differentiation characteristics of antigen specific T
cells<sup><xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R4" ref-type="bibr">4</xref></sup>. In addition studies suggest TCR interactions with self-pMHC also impact
the na&#x000ef;ve T cell response to foreign-pMHC<sup><xref rid="R5" ref-type="bibr">5</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref></sup>. Thymic positive
selection and na&#x000ef;ve T cell homeostasis require low affinity TCR recognition of
self-pMHC ligands<sup><xref rid="R12" ref-type="bibr">12</xref>&#x02013;<xref rid="R16" ref-type="bibr">16</xref></sup>, but there is controversy about how such interactions
affect the subsequent response to foreign-pMHC: published studies argue self-pMHC recognition
enhances<sup><xref rid="R6" ref-type="bibr">6</xref></sup> or diminishes<sup><xref rid="R7" ref-type="bibr">7</xref></sup> the response to foreign antigens, or selectively
impairs sensitivity to low-affinity foreign ligands<sup><xref rid="R14" ref-type="bibr">14</xref></sup>. However, those reports investigated the impact of self-pMHC withdrawal
rather than studying how the degree of self-pMHC sensitivity influences the T cell response to
foreign-pMHC.</p><p id="P3">Homeostatic TCR interactions with self-pMHC are thought to be of very low affinity
and involve recognition of multiple self-peptides by an individual T cell clone, precluding
direct assessment of self-pMHC recognition characteristics in the polyclonal T cell pool.
However, differences in the expression of the cell surface protein CD5 have proven to be a
valuable surrogate for the strength of the TCR-self-pMHC interactions<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R17" ref-type="bibr">17</xref>&#x02013;<xref rid="R21" ref-type="bibr">21</xref></sup>. CD5 expression on na&#x000ef;ve T cells
accurately predicts basal TCR signaling intensity and the capacity of T cells to rapidly
engage key TCR signaling pathways<sup><xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref></sup>, and correlates with the ability of
na&#x000ef;ve CD8<sup>+</sup> T cells to respond to homeostatic cues<sup><xref rid="R22" ref-type="bibr">22</xref>&#x02013;<xref rid="R26" ref-type="bibr">26</xref></sup>. However, the underlying basis for the distinct response characteristics of
na&#x000ef;ve CD5<sup>lo</sup> and CD5<sup>hi</sup> populations is unclear, as is the impact
of these differences on reactivity toward foreign-pMHC.</p><p id="P4">Recent studies used CD5 expression on na&#x000ef;ve CD4<sup>+</sup> T cells
to correlate the strength of self-pMHC interaction with foreign-pMHC reactivity<sup><xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref></sup>.
In one study, analysis of TCR transgenic mice suggested a direct correlation between the
abundance of cell surface CD5 and the ability to bind cognate foreign-pMHC tetramers<sup><xref rid="R9" ref-type="bibr">9</xref></sup>, suggesting TCR affinity for self-pMHC predicts
the affinity for foreign-pMHC. Those authors observed more vigorous responses by
CD5<sup>hi</sup> than CD5<sup>lo</sup> na&#x000ef;ve CD4<sup>+</sup> T cells toward
foreign-pMHC. Another report failed to observe any correlation between CD5 expression and TCR
affinity for foreign-pMHC ligands, however, and found that CD5<sup>lo</sup> T cells expanded
more efficiently than CD5<sup>hi</sup> cells during the primary response to foreign
antigen<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. Hence, whether and how CD5 expression predicts the capacity of
na&#x000ef;ve T cells to bind to and/or respond toward foreign-pMHC ligands is unclear.</p><p id="P5">Here, we report that CD5<sup>hi</sup> and CD5<sup>lo</sup> na&#x000ef;ve
CD8<sup>+</sup> T cells differ in gene expression characteristics and that the
CD5<sup>hi</sup> population manifests improved clonal recruitment and expansion in response
to foreign-pMHC. These response differences did not correlate with the strength of the TCR
interaction with foreign-pMHC, but CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T
cells showed superior utilization of <italic>in vivo</italic> inflammatory signals. Our data
suggest pre-determined heterogeneity among na&#x000ef;ve T cells dictates their capacity to
respond to foreign antigens, with consequences for diversity of the functional T cell
repertoire. Moreover, the finding that T cells with strong reactivity toward self-pMHC
dominate the foreign-pMHC response has implications for outgrowth of autoreactive T cells.</p><sec sec-type="results" id="S1"><title>Results</title><sec id="S2"><title>Distinct phenotype of CD5<sup>hi</sup> and CD5<sup>lo</sup> CD8<sup>+</sup> T
cells</title><p id="P6">We first examined phenotypic differences between na&#x000ef;ve
(CD44<sup>lo</sup>CD122<sup>lo</sup>) CD5<sup>lo</sup> and CD5<sup>hi</sup>
CD8<sup>+</sup> T cells. Extending previous work<sup><xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup> CD5<sup>hi</sup> cells were slightly larger, had
elevated expression of CD44 and modestly increased interleukin 2R&#x003b2; (CD122) and
IL-7R&#x003b1; (CD127) expression, but slightly lower TCR, CD8<sup>+</sup> and
CD62L expression compared to the CD5<sup>lo</sup> population (<xref rid="F1" ref-type="fig">Fig. 1a</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 1a&#x02013;c</xref>). The CD5<sup>hi</sup> na&#x000ef;ve
CD8<sup>+</sup> T cell population also showed elevated expression of T-bet and
eomesodermin (transcription factors associated with activated CD8<sup>+</sup> T
cell differentiation<sup><xref rid="R28" ref-type="bibr">28</xref></sup>) and a subset of
CD5<sup>hi</sup> cells expressed the chemokine receptor CXCR3 (<xref rid="F1" ref-type="fig">Fig. 1a</xref>). The phenotypic characteristics of CD5<sup>hi</sup>
na&#x000ef;ve CD8<sup>+</sup> T cells had some similarities to memory
CD8<sup>+</sup> T cells. However, the frequency and phenotype of
CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cells was similar in
IL-15-deficient mice, which lack typical CD8<sup>+</sup> memory T cells<sup><xref rid="R29" ref-type="bibr">29</xref></sup> (<xref rid="F1" ref-type="fig">Fig.
1b</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig.
1b,c</xref>). Hence, the CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cell
population neither derives from nor depends on memory-phenotype CD8<sup>+</sup> T
cells.</p><p id="P7">To determine whether the CD5<sup>hi</sup> and CD5<sup>lo</sup> populations are
stable, we sorted polyclonal na&#x000ef;ve CD8<sup>+</sup> T cells into
CD5<sup>hi</sup> and CD5<sup>lo</sup> populations (reflecting the upper and lower
20% of CD5 distribution, respectively), and congenically distinct cell populations
were co-transferred into normal recipients. Both transferred populations maintained
distinct CD5 expression and persisted for at least 8 weeks, indicating equivalent steady
state survival (similar to studies on na&#x000ef;ve CD4<sup>+</sup> T
cells<sup><xref rid="R9" ref-type="bibr">9</xref></sup>) (<xref rid="F1" ref-type="fig">Fig. 1c,d</xref>
<bold>and data not shown</bold>). The majority of donor cells maintained a na&#x000ef;ve
phenotype, though a fraction of CD5<sup>hi</sup> cells converted to CD44<sup>hi</sup>
phenotype (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig.
1d</xref>), consistent with their enhanced response to homeostatic cues<sup><xref rid="R22" ref-type="bibr">22</xref>&#x02013;<xref rid="R26" ref-type="bibr">26</xref></sup>.</p><p id="P8">Biochemical approaches indicate a correlation between CD5 abundance and the
degree of basal TCR signaling<sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>, however such
methods cannot permit assessment of TCR signal strength in individual cells. Hence we
examined Nur77<sup>gfp</sup> transgenic reporter mice, in which green fluorescent protein
(GFP) expression provides a sensitive readout of TCR signaling<sup><xref rid="R30" ref-type="bibr">30</xref></sup>. For CD8<sup>+</sup> and
CD4<sup>+</sup> na&#x000ef;ve T cell subsets, CD5<sup>hi</sup> cells showed
increased GFP expression compared to the CD5<sup>lo</sup> population (<xref rid="F1" ref-type="fig">Fig. 1e</xref>), and this correlation held for Nur77<sup>gfp</sup>
expression in H-Y and OT-I TCR transgenic CD8<sup>+</sup> T cells (which reflect
CD5<sup>lo</sup> and CD5<sup>hi</sup> populations, respectively)<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R25" ref-type="bibr">25</xref></sup> (<xref rid="F1" ref-type="fig">Fig. 1f</xref>). Thus,
CD5<sup>hi</sup> and CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T cells are
distinct, stable populations, with CD5<sup>hi</sup> cells displaying characteristics of
cells that undergo more intense or frequent TCR interactions with self-pMHC.</p></sec><sec id="S3"><title>Distinct transcriptional profiles of CD5<sup>hi</sup> and CD5<sup>lo</sup>
CD8<sup>+</sup> T cells</title><p id="P9">We next conducted gene expression analysis on polyclonal CD5<sup>hi</sup> and
CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T cells. In total, 57 unique
genes were significantly changed by at least 2-fold (47 upregulated, 10 downregulated) in
CD5<sup>hi</sup> relative to CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T
cells (<xref rid="T1" ref-type="table">Table 1</xref>). Among genes upregulated in
CD5<sup>hi</sup> cells were those for the transcription factors Eomes, T-bet, Helios and
Id3, many of which play a key role in activated T cell differentiation<sup><xref rid="R28" ref-type="bibr">28</xref></sup>, and molecules associated with trafficking and
adhesion of effector T cells (CXCR3, XCL1 and CD44). Conversely, the kinase Itk (which can
serve as a negative regulator of T-bet<sup><xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup>) was downregulated in CD5<sup>hi</sup>
cells.</p><p id="P10">We further investigated the expression of XCL1, since it has been associated
with efficient <italic>in vivo</italic> activation of CD8<sup>+</sup> T cells (via
enhancing T cell-dendritic cell colocalization)<sup><xref rid="R33" ref-type="bibr">33</xref></sup>. After brief <italic>in vitro</italic> stimulation of splenocytes,
XCL1 protein expression was biased to a sub-population of CD5<sup>hi</sup> na&#x000ef;ve
CD8+ T cells (<xref rid="F2" ref-type="fig">Fig. 2a,b</xref>; <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 2a</xref>). Expression of CXCR3 and
T-bet also marked a subset of CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T
cells (<xref rid="F2" ref-type="fig">Fig. 2b</xref>)(<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 2a</xref>). However, although
memory phenotype (CD44<sup>hi</sup>) CD8<sup>+</sup> T cells typically
co-expressed these proteins, there was little coordinated expression in the na&#x000ef;ve
CD5<sup>hi</sup> pool (<xref rid="SD1" ref-type="supplementary-material">Supplementary
Fig. 2b,c</xref>), indicating considerable heterogeneity within the CD5<sup>hi</sup>
na&#x000ef;ve CD8<sup>+</sup> T cell population.</p><p id="P11">Most individual gene expression differences between CD5<sup>hi</sup> and
CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T cell populations were subtle
(<xref rid="T1" ref-type="table">Table 1</xref>), hence we explored whether there were
changes in expression of gene sets. For a focused comparison, we used a
&#x003c7;<sup>2</sup> test to align differences in CD5<sup>hi</sup> and CD5<sup>lo</sup>
transcription with a database generated by ImmGen Consortium (Immgen.org), which had
comprehensively defined patterns of gene expression following activation and
differentiation of CD8<sup>+</sup> T cells<sup><xref rid="R34" ref-type="bibr">34</xref></sup>. In that earlier work, a temporal analysis of gene expression over
the course of the immune response allowed for the characterization of 10 clusters of
correlated gene expression<sup><xref rid="R34" ref-type="bibr">34</xref></sup>. We
investigated how expression of genes in these clusters were regulated in the
CD5<sup>hi</sup> and CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T cell
subsets. This analysis revealed that the CD5<sup>hi</sup> population expressed
significantly higher proportion of genes that characterize two early stages of the
CD8<sup>+</sup> T cell response and are associated with preparation for cell
cycle (Cluster II) and active cell cycle and division (Cluster III) (<xref rid="F2" ref-type="fig">Fig. 2c</xref>, <xref rid="T2" ref-type="table">Table 2</xref>). A more
moderate (but still highly significant) correlation with Cluster X, which defines genes
expressed at late effector and memory stages (<xref rid="F2" ref-type="fig">Fig.
2c</xref>, <xref rid="T2" ref-type="table">Table 2</xref>). Together, these data suggest
the CD5<sup>hi</sup> population is better poised for initial activation, compared to the
CD5<sup>lo</sup> population.</p></sec><sec id="S4"><title>Enhanced expansion of CD5<sup>hi</sup> CD8<sup>+</sup> T cells in response to
infection</title><p id="P12">We next directly tested whether CD5<sup>hi</sup> and CD5<sup>lo</sup>
na&#x000ef;ve CD8<sup>+</sup> T cells differ in their primary immune response
against foreign antigen. In initial studies we assayed polyclonal CD8<sup>+</sup>
T cells specific for the H-2K<sup>b</sup> restricted vaccinia virus epitope
B8R<sub>20&#x02013;27</sub> (B8R), which are present at a frequency of ~1 per
1&#x02013;2 &#x000d7; 10<sup>4</sup> CD8<sup>+</sup> T cells in unimmunized
C57BL/6 mice<sup><xref rid="R35" ref-type="bibr">35</xref></sup>. Na&#x000ef;ve
CD44<sup>lo</sup> CD8<sup>+</sup> T cells were sorted by flow cytometry into
congenically distinct CD5<sup>lo</sup> and CD5<sup>hi</sup> populations, and ~1.5
&#x000d7; 10<sup>6</sup> of each population co-transferred into recipients that were
subsequently infected with LM-B8R, a recombinant attenuated <italic>Listeria
monocytogenes</italic> expressing the B8R<sub>20&#x02013;27</sub> and the
H-2K<sup>b</sup> restricted ovalbumin peptide (OVA<sub>257&#x02013;264</sub>: Ova).
Assuming ~20% engraftment following adoptive transfer, this should seed ~20
B8R/K<sup>b</sup> specific cells from each donor. At day 7 following infection, pMHC
tetramer staining was used to identify responsive CD5<sup>hi</sup> and CD5<sup>lo</sup>
donor cells, and the ratio (<xref rid="F3" ref-type="fig">Fig. 3a</xref>) and absolute
numbers (<xref rid="F3" ref-type="fig">Fig. 3b</xref>) of each population was determined.
In most cases, the CD5<sup>hi</sup> donor population dominated the response, on average
accounting of ~95% of the B8R/K<sup>b</sup>-specific population (<xref rid="F3" ref-type="fig">Fig. 3a,b</xref>), although occasionally progeny of the CD5<sup>lo</sup>
donors were more frequent (double dagger symbol in <xref rid="F3" ref-type="fig">Fig.
3a,b</xref>). Tetramer binding may fail to identify all functionally responsive cells
but similar results were obtained using peptide-induced interferon-&#x003b3;
(IFN-&#x003b3;) production to identify antigen specific T cells (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3a,b</xref>). At memory phase
following priming and also during a recall response, the progeny of CD5<sup>hi</sup> donor
cells maintained dominance over those from the CD5<sup>lo</sup> pool (<xref rid="F3" ref-type="fig">Fig. 3a</xref>). The fact that this skewing was not exacerbated during
the recall response indicates memory cells generated from CD5<sup>lo</sup> and
CD5<sup>hi</sup> cells had similar re-expansion potential.</p><p id="P13">The dominance of CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cell
responses was not unique to B8R/K<sup>b</sup> specific T cells or to Listeria infection:
The OVA/K<sup>b</sup> specific response induced by LM-B8R infection and the
gp33/D<sup>b</sup> specific response induced by lymphocytic choriomeningitis virus
(LCMV) infection were also biased to the CD5<sup>hi</sup> donor cells (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3c,d</xref>). Beyond individual
antigen specificities, the bulk pathogen-specific response &#x02013; identified as donor
CD8<sup>+</sup> T cells that had acquired an antigen-experienced
CD44<sup>hi</sup>, CD8<sup>lo</sup>, CD11a<sup>hi</sup> phenotype &#x02013; also showed
an advantage for the CD5<sup>hi</sup> donor pool, albeit less pronounced than observed for
individual pMHC specific responses (<xref rid="F3" ref-type="fig">Fig. 3c</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3e</xref>).</p><p id="P14">The preferential expansion of the CD5<sup>hi</sup> donor population did not
reflect greater intrinsic capacity of these cells for TCR-induced proliferation, as
CD5<sup>lo</sup> and CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cells
proliferated similarly upon <italic>in vitro</italic> stimulation with anti-CD3 plus
anti-CD28 (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig.
3f</xref>), consistent with earlier studies<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R24" ref-type="bibr">24</xref></sup>. The enhanced CD5<sup>hi</sup> T cell B8R/K<sup>b</sup>-specific
response was also seen when using <italic>Rag-1</italic><sup>&#x02212;/&#x02212;</sup>
recipient mice, ruling out a required contribution of host T or B lymphocytes (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3g</xref>).</p><p id="P15">Since na&#x000ef;ve CD5<sup>hi</sup> cells express intermediate amounts of CD44,
it was formally possible that some memory-phenotype T cells had contaminated the
CD5<sup>hi</sup> donor population. Yet when CD5<sup>hi</sup> and CD5<sup>lo</sup> donor
populations were sorted to have equally low CD44 expression, the CD5<sup>hi</sup> donor
population still dominated the response to LM-B8R (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3h</xref>), arguing against memory
cell contamination in our studies. The differential response of CD5<sup>hi</sup> and
CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T cells suggested that reactivity
improves proportionally to increasing CD5 expression. To explore this, we measured the
response to infection of CD5<sup>lo</sup> and CD5<sup>hi</sup> populations relative to
total na&#x000ef;ve CD8<sup>+</sup> T cell pool (containing the full spectrum of
CD5 expression). The CD5<sup>lo</sup> population expanded less than bulk na&#x000ef;ve
CD8<sup>+</sup> T cells, while the CD5<sup>hi</sup> cells proliferated more
(<xref rid="F3" ref-type="fig">Fig. 3d,e</xref>), suggesting that CD5<sup>lo</sup> and
CD5<sup>hi</sup> populations represent the extremes of a continuum in reactivity to
foreign antigen.</p><p id="P16">Given that the CD5<sup>hi</sup> population is heterogeneous (<xref rid="F2" ref-type="fig">Fig. 2b</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 2c</xref>), it was possible that a small subset within this pool was
responsible for their superior antigen-specific responses. We investigated this hypothesis
by subdividing the na&#x000ef;ve CD5<sup>hi</sup> population based on CXCR3 expression,
since this chemokine receptor has been associated with enhanced <italic>in vivo</italic>
antigen detection by memory CD8<sup>+</sup> T cells<sup><xref rid="R36" ref-type="bibr">36</xref>,<xref rid="R37" ref-type="bibr">37</xref></sup>. We sorted
congenic populations of na&#x000ef;ve CD5<sup>hi</sup> cells into CXCR3<sup>lo</sup> and
CXCR3<sup>hi</sup> populations, and tested their response toward LM-B8R infection using
the co-transfer model described above. We observed that expansion of the
CXCR3<sup>hi</sup> CD5<sup>hi</sup> population was significantly greater than that of
the CXCR3<sup>lo</sup> CD5<sup>hi</sup> subset, in both the B8R/K<sup>b</sup> specific and
bulk CD44<sup>hi</sup> responder populations (<xref rid="F3" ref-type="fig">Fig.
3f</xref>). However, these differences were of lower magnitude than those between
CD5<sup>hi</sup> and CD5<sup>lo</sup> populations (compare <xref rid="F3" ref-type="fig">Figs. 3A,B and F</xref>), arguing against the hypothesis that a small subset of
CD5<sup>hi</sup> cells accounts for all the enhanced reactivity of this population.</p><p id="P17">Aside from TCR signals, CD8<sup>+</sup> T cell responses are strongly
influenced by cytokines. Na&#x000ef;ve CD5<sup>hi</sup> CD8<sup>+</sup> T cells
are more reactive to &#x003b3;<sub>c</sub> cytokines<sup><xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> and possess enhanced
ability to produce IL-2 following TCR stimulation<sup><xref rid="R11" ref-type="bibr">11</xref></sup>, which might induce autocrine IL-2R signaling. Also, the capacity of
inflammatory cues to augment the magnitude of CD8<sup>+</sup> T cell responses
involves sustained upregulation of CD25 (ref<sup><xref rid="R38" ref-type="bibr">38</xref></sup>). To test whether CD25 expression impacts the differential response of
CD5<sup>lo</sup> and CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cells, we
assessed reactivity of CD25-deficient polyclonal CD8<sup>+</sup> T cells,
generated in mixed bone marrow chimeras, to avoid the lymphoproliferation and autoimmunity
that occurs in CD25-deficient mice<sup><xref rid="R39" ref-type="bibr">39</xref></sup>.
The distribution of CD5 expression was similar in wild-type and
<italic>Cd25</italic><sup>&#x02212;/&#x02212;</sup> resting na&#x000ef;ve
CD8<sup>+</sup> T cells (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 3i</xref>). As expected, the B8R/K<sup>b</sup>-specific wild-type
CD5<sup>hi</sup> population expanded more than wild-type CD5<sup>lo</sup> cells (<xref rid="F3" ref-type="fig">Fig. 3g</xref>) but, while CD25 deficiency did not have a
statistically significant effect on the response by B8R/K<sup>b</sup>-specific
CD5<sup>lo</sup> cells, the response by
<italic>Cd25</italic><sup>&#x02212;/&#x02212;</sup> CD5<sup>hi</sup> cells was modestly
but significantly impaired (<xref rid="F3" ref-type="fig">Fig. 3g</xref>). While these
data suggest the CD5<sup>hi</sup> pool may be more reliant on IL-2 responsiveness, the
responses of CD5<sup>hi</sup> and CD5<sup>lo</sup> cells were not normalized by CD25
deficiency, indicating that elevated IL-2 sensitivity cannot fully account for the
differences between these populations.</p><p id="P18">Together these data indicate that the antigen specific response to pathogens is
dominated by CD5<sup>hi</sup> na&#x000ef;ve CD8+ T cells.</p></sec><sec id="S5"><title>Distinct clonal responses by CD5<sup>hi</sup> and CD5<sup>lo</sup>
CD8<sup>+</sup> T cells</title><p id="P19">Our analysis of bulk naive CD8<sup>+</sup> T cell responses could not
determine whether the differential expansion of CD5<sup>hi</sup> and CD5<sup>lo</sup>
na&#x000ef;ve CD8<sup>+</sup> T cell populations reflected enhanced responses by
all antigen reactive CD5<sup>hi</sup> cells, or dominance by a small number of
CD5<sup>hi</sup> CD8<sup>+</sup> T cell clones. This is relevant because
expansion characteristics of individual antigen specific na&#x000ef;ve T cells can vary
considerably<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R40" ref-type="bibr">40</xref>&#x02013; <xref rid="R42" ref-type="bibr">42</xref></sup>. Accordingly, we reduced the number of
adoptively transferred na&#x000ef;ve CD44<sup>lo</sup> CD5<sup>hi</sup> or
CD5<sup>lo</sup> polyclonal na&#x000ef;ve CD8<sup>+</sup> T cells to
25&#x02013;30 &#x000d7; 10<sup>3</sup> cells. Based on the frequency of B8R/K<sup>b</sup>
specific precursors<sup><xref rid="R35" ref-type="bibr">35</xref></sup>, 20%
engraftment would seed ~1 B8R/K<sup>b</sup> specific donor CD8<sup>+</sup> T cell
per 3&#x02013;5 donor cell cohorts, giving an average predicted response rate of
~27.5%. To increase the efficiency of detecting a clonal response, we used
simultaneous transfer of up to 8 congenically distinct donor populations into a single
recipient, as described by others<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R40" ref-type="bibr">40</xref></sup>
(<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 4</xref>). Using
CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cells, ~ 24% (46/188)
of transfers led to a B8R/K<sup>b</sup> specific response, which was not significantly
different from the predicted frequency (<xref rid="F4" ref-type="fig">Fig. 4a</xref>) and
consistent with studies using na&#x000ef;ve OT-I T cells<sup><xref rid="R40" ref-type="bibr">40</xref></sup>. In contrast, adoptive transfer of 25 &#x000d7;
10<sup>3</sup> CD5<sup>lo</sup> cells led to no detectable B8R/K<sup>b</sup> specific
donor responses (0/40), significantly below the predicted rate (see legend to <xref rid="F4" ref-type="fig">Fig. 4a</xref>). Increasing the input of CD5<sup>lo</sup> donor
cells to 100 &#x000d7; 10<sup>3</sup> led to detectable responses, but only in 14%
(18/125) of transfers (<xref rid="F4" ref-type="fig">Fig. 4a</xref>). This response rate
suggests that less than 1/7<sup>th</sup> the expected number of CD5<sup>lo</sup>
CD8+ T cell precursors were capable of mounting a detectable response. Examining
non-clonal responses by 375 &#x000d7; 10<sup>3</sup> CD5<sup>hi</sup> or CD5<sup>lo</sup>
donor cells showed that &#x0003e;95% of CD5<sup>hi</sup> (23/24) but only 70%
of donor CD5<sup>lo</sup> populations (14/20) mounted a response (<xref rid="F4" ref-type="fig">Fig. 4b</xref>), further demonstrating the reduced response rate in the
CD5<sup>lo</sup> pool.</p><p id="P20">Furthermore, the mean clonal expansion magnitude (&#x0201c;burst size&#x0201d;)
of the responding CD5<sup>lo</sup> population (from the 100 &#x000d7; 10<sup>3</sup> cell
transfer) was significantly smaller than that of CD5<sup>hi</sup> cells (25&#x02013;30
&#x000d7; 10<sup>3</sup> cell transfer)(<xref rid="F4" ref-type="fig">Fig. 4b</xref>). It
was also notable that the two largest clonal responses were seen for cells derived from
CD5<sup>hi</sup> precursors, and were 10&#x02013;100 fold greater than the largest
CD5<sup>lo</sup> clonal response (arrows in <xref rid="F4" ref-type="fig">Fig.
4B</xref>): Modeling the outcome if all the measured CD5<sup>hi</sup> and CD5<sup>lo</sup>
clonal responses had occurred in a single animal, those two clones would account for
nearly 80% of the B8R/K<sup>b</sup> specific population (data not shown).</p><p id="P21">Hence, clonal analysis revealed two ways in which the CD5<sup>hi</sup> and
CD5<sup>lo</sup> T cell responses differ: First, the CD5<sup>hi</sup> population
displayed a markedly greater response rate. Second, even among cells that did engage in
the B8R/K<sup>b</sup> specific response, the average burst size of the CD5<sup>lo</sup>
pool was reduced compared to CD5<sup>hi</sup> responders. Together, these differences can
account for much of the expansion advantage of the CD5<sup>hi</sup>pool.</p></sec><sec id="S6"><title>Efficient recruitment of CD5<sup>hi</sup> CD8+ T cells into the immune
response</title><p id="P22">The increased clonal recruitment of CD5<sup>hi</sup> versus CD5<sup>lo</sup>
cells might reflect preferential initial activation of CD5<sup>hi</sup> cells, or similar
initial response by both populations, followed by improved proliferation/survival of the
CD5<sup>hi</sup> population. The superior response by CD5<sup>hi</sup> cells was already
apparent at days 3&#x02013;4 of the <italic>in vivo</italic> response to LM-B8R (<xref rid="F5" ref-type="fig">Fig. 5a</xref>), hence we next investigated whether
CD5<sup>hi</sup> cells were preferentially activated during the initial response to
infection. This was not feasible using adoptive transfer of polyclonal cells, and to
determine the response of endogenous CD5<sup>hi</sup> and CD5<sup>lo</sup> cells it was
first necessary to test whether CD5 expression changes during short term <italic>in
vivo</italic> activation. Nur77<sup>gfp</sup> mice were injected with anti-CD3 i.v., and
5h later T cell activation was determined by induction of CD69 and Nur77<sup>gfp</sup>.
Despite robust activation, na&#x000ef;ve CD8+ T cells showed no change in CD5
expression (<xref rid="F5" ref-type="fig">Fig. 5b,c</xref>), indicating that
CD5<sup>hi</sup> and CD5<sup>lo</sup> na&#x000ef;ve populations could still be
distinguished. Next, Nur77<sup>gfp</sup> mice were infected with LM-B8R and 5h later
splenic CD8<sup>+</sup> T cells specific for B8R/K<sup>b</sup> and for an
irrelevant antigen (M57/K<sup>b</sup> with the murine cytomegalovirus (MCMV) epitope, M57)
were enriched using MHC class I tetramer capture. Following LM-B8R infection, activated
na&#x000ef;ve CD8<sup>+</sup> T cells were evident among the
B8R/K<sup>b</sup>&#x02013;specific population but not in the control
M57/K<sup>b</sup>-specific population (<xref rid="F5" ref-type="fig">Fig. 5d</xref>), and
the activated B8R/K<sup>b</sup>&#x02013;specific population was enriched for
CD5<sup>hi</sup> cells (<xref rid="F5" ref-type="fig">Fig. 5e,f</xref>). These data
suggest that initial recruitment and/or activation favors the CD5<sup>hi</sup>
na&#x000ef;ve CD8+ T cell pool during the response to foreign antigen.</p></sec><sec id="S7" sec-type="intro"><title>CD5<sup>lo</sup> and CD5<sup>hi</sup> cells show similar foreign pMHC binding
characteristics</title><p id="P23">Some studies suggest CD5 expression on na&#x000ef;ve TCR transgenic
CD4<sup>+</sup> T cells correlates with the TCR affinity for foreign-pMHC
ligands, indicated by increased pMHC tetramer labeling of CD5<sup>hi</sup> versus
CD5<sup>lo</sup> clones<sup><xref rid="R9" ref-type="bibr">9</xref></sup>. However, we
found comparable pMHC tetramer staining intensities were observed on CD5<sup>hi</sup> and
CD5<sup>lo</sup> na&#x000ef;ve CD8+ T cell populations isolated by tetramer
enrichment from unimmunized mice, (<xref rid="F6" ref-type="fig">Fig. 6a</xref>),
suggesting similar capacities for foreign-pMHC ligand binding. Furthermore,
B8R/K<sup>b</sup> tetramer geometric mean fluorescence intensity (gMFI) was not
significantly different on effector cells derived from clonal CD5<sup>lo</sup> and
CD5<sup>hi</sup> responses revealed that intensity did not significantly differ for
antigen-specific progeny of CD5<sup>lo</sup> versus CD5<sup>hi</sup> clones, whereas the
burst size of CD5<sup>hi</sup> clones was significantly higher than that of
CD5<sup>lo</sup> clones (<xref rid="F6" ref-type="fig">Fig. 6b</xref>). Thus, we
observed minimal correlation between pMHC tetramer-staining intensity and either CD5
expression or clonal expansion characteristics of specific CD8<sup>+</sup> T
cells.</p><p id="P24">It was also possible that foreign antigen specific T cells are selectively
under-represented in the CD5<sup>lo</sup> pool. We did observe modest, but in some cases
significant, skewing to higher CD5 expression within the foreign-pMHC tetramer binding
na&#x000ef;ve CD8<sup>+</sup> T cell pool (<xref rid="F6" ref-type="fig">Fig.
6c</xref>), and accordingly there were slightly more B8R/K<sup>b</sup> specific cells in
sorted CD5<sup>hi</sup> versus CD5<sup>lo</sup> populations (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 5</xref>). However, such skewing
only contributed an average ~1.5-fold increase in antigen-specific precursors within the
CD5<sup>hi</sup> population, relative to CD5<sup>lo</sup> cells, which could not explain
the larger differences in clonal recruitment or population expansion of antigen specific
CD5<sup>hi</sup> versus CD5<sup>lo</sup> cells (<xref rid="F3" ref-type="fig">Figs.
3</xref>,<xref rid="F4" ref-type="fig">4</xref>).</p><p id="P25">To avoid potential artifacts from the tetramer enrichment protocol, we analyzed
four TCR transgenic lines which differ in CD5 surface expression, following the order H-Y
&#x0003c; F5 &#x0003c; P14 &#x0003c; OT-I<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup> (<xref rid="F6" ref-type="fig">Fig. 6d</xref>). All the TCR transgenic strains bound cognate
pMHC tetramers with similar efficiency in dose titration (<xref rid="F6" ref-type="fig">Fig. 6e</xref>) indicating that, in contrast to studies with CD4<sup>+</sup>
TCR-transgenic T cells<sup><xref rid="R9" ref-type="bibr">9</xref></sup>, CD5<sup>lo</sup>
versus CD5<sup>hi</sup> expression did not predict the strength of foreign-pMHC ligand
binding to TCR-transgenic CD8<sup>+</sup> T cells. Interpreting tetramer staining
may be complicated by the finding that CD8 and TCR expression are reduced on na&#x000ef;ve
CD5<sup>hi</sup> versus CD5<sup>lo</sup> CD8<sup>+</sup> T cells (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 1a</xref>), and CD8
contributes to Class I pMHC tetramer binding<sup><xref rid="R43" ref-type="bibr">43</xref></sup>. Hence we also tested reactivity (as CD69 induction) of
CD5<sup>hi</sup> and CD5<sup>lo</sup> TCR transgenic T cells to their cognate foreign
ligands in dose titration. Although differences in antigen sensitivity were seen, they did
not correlate with CD5 expression levels (<xref rid="F6" ref-type="fig">Fig. 6f</xref>):
for example CD5<sup>hi</sup> OT-I and CD5<sup>lo</sup> F5 CD8<sup>+</sup> T cells
showed similar antigen sensitivity. Instead, dose sensitivity corresponded with peptide
binding to the relevant MHC molecules (<xref rid="F6" ref-type="fig">Fig. 6g</xref>).
Hence, these data indicate that CD5 expression predicted neither tetramer binding nor in
vitro antigen sensitivity of na&#x000ef;ve CD8<sup>+</sup> T cells.</p><p id="P26">An expectation from our findings would be that CD5<sup>hi</sup> and
CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T cells with identical TCRs would
display distinct response characteristics. This hypothesis was supported by earlier
studies using TCR transgenic CD8<sup>+</sup> T cells sorted into CD5<sup>hi</sup>
and CD5<sup>lo</sup> pools<sup><xref rid="R24" ref-type="bibr">24</xref></sup>, but as CD5
levels are typically determined during thymic development, we sought to manipulate
positive selection to produce cells with distinct CD5 expression levels. Bone marrow
chimeras were generated using OT-I TCR transgenic donor marrow to reconstitute wild-type
or &#x003b2;2m<sup>&#x02212;/&#x02212;</sup> hosts &#x02013; in the latter, positive
selection is mediated by hematopoietic cells, resulting in generation of OT-I cells with
lower CD5<sup>lo</sup> expression (<xref rid="F6" ref-type="fig">Fig. 6H</xref> and data
not shown). When assessed for their response to LM-OVA infection, CD5<sup>hi</sup> OT-I
expanded ~3&#x02013;4-fold greater than the CD5<sup>lo</sup> OT-I population (<xref rid="F6" ref-type="fig">Fig. 6I</xref>) indicating that CD5 expression levels correlated
with the magnitude of the immune response, even when TCR specificity was normalized. In
aggregate, our data suggest that the advantage of CD5<sup>hi</sup> over CD5<sup>lo</sup>
na&#x000ef;ve CD8<sup>+</sup> T cells in their response to foreign antigen cannot
be explained by differences in precursor frequency or avidity for foreign pMHC
ligands.</p></sec><sec id="S8"><title>Na&#x000ef;ve CD5<sup>hi</sup> cells utilize inflammatory signals during the response
to antigen</title><p id="P27">Besides TCR signals, the magnitude of the CD8<sup>+</sup> T cell
response is influenced by inflammatory cues<sup><xref rid="R44" ref-type="bibr">44</xref>,<xref rid="R45" ref-type="bibr">45</xref></sup>, hence we next tested the
impact of inflammation on the response of CD5<sup>hi</sup> and CD5<sup>lo</sup>
na&#x000ef;ve CD8<sup>+</sup> T cells. Since CD8<sup>+</sup> T cell
expansion is reduced in the absence of innate cues<sup><xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref></sup> this system was not
suitable for analysis of rare antigen-specific polyclonal CD8<sup>+</sup> T cells,
hence we used H-Y and OT-I TCR transgenic T cells models as examples of CD5<sup>lo</sup>
and CD5<sup>hi</sup> clones, respectively. Low numbers of na&#x000ef;ve H-Y and OT-I
CD8<sup>+</sup> T cells from were transferred into congenic hosts and stimulated
by injection of dendritic cells (DCs) loaded with cognate peptides, with or without
co-infection using wild-type &#x00394;actA LM, which expresses no stimulatory antigens for
either TCR transgenic, as a source of inflammatory stimulation. OVA peptide was used to
stimulate OT-I cells, while H-Y T cells were stimulated with C2A, a variant of the Smcy
peptide that enhances HY TCR recognition without altering MHC binding<sup><xref rid="R48" ref-type="bibr">48</xref></sup> (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 6a&#x02013;c</xref>), to minimize differences in ligand dose
sensitivity of H-Y and OT-I T clones.</p><p id="P28">As expected, antigen-bearing DCs alone provoked modest responses by both H-Y and
OT-I cells (<xref rid="F7" ref-type="fig">Fig. 7a</xref>) and, when corrected for donor
cell engraftment, there was moderately increased expansion of the OT-I versus H-Y pool
(<xref rid="F7" ref-type="fig">Fig. 7b</xref>). LM co-infection enhanced expansion by
the OT-I population, as anticipated from earlier studies<sup><xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R49" ref-type="bibr">49</xref></sup>, but did not
increase H-Y T cell expanasion, and in fact caused a slight reduction in cell numbers
(<xref rid="F7" ref-type="fig">Fig. 7a</xref>). Accordingly, LM co-infection greatly
increased the difference between HY and OT-I population sizes (<xref rid="F7" ref-type="fig">Fig. 7b</xref>). Similar effects were seen using LCMV co-infection (<xref rid="F7" ref-type="fig">Fig. 7c,d</xref>) and preliminary studies using
co-administration of the TLR9 agonist CpG yielded comparable results (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 6d</xref>). These data suggest
that, while the CD5<sup>hi</sup> clone OT-I responds to pro-inflammatory signals with
enhanced expansion, this pathway is not operative for CD5<sup>lo</sup> H-Y
CD8<sup>+</sup> T cells. The pro-inflammatory cytokines IL-12 and Type-I IFN act
as a &#x0201c;3<sup>rd</sup> signals&#x0201d; to promote CD8<sup>+</sup> T cell
responses<sup><xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref></sup>, but preliminary <italic>in vitro</italic> experiments
did not suggest differences in the responses of HY and OT-I T cells to those cytokines
(data not shown), indicating a more complex basis for the altered response. Nevertheless,
our data suggest qualitative differences in the response of CD5<sup>hi</sup> versus
CD5<sup>lo</sup> CD8<sup>+</sup> T cells when foreign antigen stimulation is
delivered in the context of innate immune cues <italic>in vivo</italic>.</p></sec></sec><sec sec-type="discussion" id="S9"><title>Discussion</title><p id="P29">Our data show that na&#x000ef;ve CD8<sup>+</sup> T cells with heightened
recognition of self-pMHC ligands display enhanced reactivity toward foreign pMHC antigens.
We confirmed and extended the utility of CD5 expression as a measure of the strength of self
ligand encounter &#x02013; showing that CD5<sup>hi</sup> cells exhibited increased
expression of the Nur77-GFP reporter (a surrogate for TCR signaling) and changes in gene
expression indicative of enhanced response sensitivity. Comparison of the <italic>in
vivo</italic> response to foreign antigen revealed multiple steps at which the
CD5<sup>hi</sup> population of na&#x000ef;ve CD8<sup>+</sup> T cells manifest an
advantage over their CD5<sup>lo</sup> counterparts: initial activation and response rates
were more efficient, the clonal burst size greater, and sensitivity to inflammatory cues
enhanced. On the other hand, we did not observe a consistent difference in the capacity of
polyclonal or TCR transgenic CD5<sup>hi</sup> versus CD5<sup>lo</sup> cells to bind to
foreign pMHC tetramers, nor did TCR transgenic models suggest a difference in foreign pMHC
response sensitivity. Taken together, our studies support a model in which the differences
between CD5<sup>hi</sup> and CD5<sup>lo</sup> na&#x000ef;ve CD8<sup>+</sup> T cells
are established prior to encounter with foreign antigen, and that numerous properties of the
CD5<sup>hi</sup> population make their responses more efficient and competitive.</p><p id="P30">Our data differ from two elegant reports that used CD5 expression to characterize
heterogeneity in the na&#x000ef;ve CD4 T cell response. While one study found that
CD5<sup>hi</sup> cells had enhanced TCR engagement with foreign pMHC ligands and superior
response to antigen in vivo<sup><xref rid="R9" ref-type="bibr">9</xref></sup>, another
reported that CD5<sup>lo</sup> and CD5<sup>hi</sup> cells had similar engagement with pMHC
ligands and that CD5<sup>lo</sup> cells showed greater in vivo expansion than their
CD5<sup>hi</sup> counterparts<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. Although we observed some skewing in the size
of the foreign pMHC tetramer binding population in favor of the CD5<sup>hi</sup> pool, this
effect was modest and average tetramer binding intensity was similar for antigen specific
CD5<sup>lo</sup> and CD5<sup>hi</sup> cells. Hence, our data and others<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>
argue against the conceptually complex model that the structural capacity to bind foreign
pMHC ligands is dictated by T cell sensitivity toward self-pMHC molecules. These
discrepancies may reflect distinct properties of CD4 and CD8<sup>+</sup> T cells (as
discussed<sup><xref rid="R9" ref-type="bibr">9</xref></sup>), although this argument
does not pertain to the divergent conclusions reached with studies on CD4 T cells<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. In
any case, our findings reinforce the concept that, at least for na&#x000ef;ve
CD8<sup>+</sup> T cells, the distinct responses of the CD5<sup>hi</sup> and
CD5<sup>lo</sup> population likely reflects pre-existing, intrinsic properties of the
cells, rather than arising from differences in foreign antigen perception.</p><p id="P31">Contrasting with our findings and others<sup><xref rid="R9" ref-type="bibr">9</xref></sup>, some reports found that CD5<sup>lo</sup> cells expanded more
effectively than CD5<sup>hi</sup> cells, despite similar foreign ligand recognition
properties<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. Significantly, recent studies argued that CD5<sup>hi</sup>
na&#x000ef;ve CD4<sup>+</sup> T cells exhibited a strong response to TCR
stimulation, but this led to increased susceptibility for activation-driven cell death
induced by IL-2<sup><xref rid="R11" ref-type="bibr">11</xref></sup>. Our data suggest that
optimal expansion of activated CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T
cells was dependent on CD25 expression, and enhanced IL-2 sensitivity (through improved
CD122 signaling) was reported in the landmark studies of Cho et al. on of homeostasis of
CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cells<sup><xref rid="R24" ref-type="bibr">24</xref></sup>. Potentially, enhanced IL-2 sensitivity is a boon to
responding CD5<sup>hi</sup> CD8<sup>+</sup> T cells, yet may be detrimental to
CD5<sup>hi</sup> CD4 T cells (at least in some situations) by making them more vulnerable
to induced cell death. It is also worth noting that the range of CD5 expression levels (and
associated basal TCR signaling) is greater in na&#x000ef;ve CD4 T cells compared to
na&#x000ef;ve CD8<sup>+</sup> T cells<sup><xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref></sup>, perhaps indicative of
distinct functional thresholds between the subsets.</p><p id="P32">Our studies build on considerable work that suggested CD5 levels correlate with
TCR engagement by self-pMHC<sup><xref rid="R9" ref-type="bibr">9</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R18" ref-type="bibr">18</xref>&#x02013;<xref rid="R21" ref-type="bibr">21</xref></sup>. Our work defines the
properties of the CD5<sup>hi</sup> population prior to antigen encounter, and mechanisms
with which these cells outcompete other na&#x000ef;ve CD8<sup>+</sup> T cell
populations during an active immune response. It is unclear whether CD5 itself contributes
to the distinct function of CD5<sup>hi</sup> versus CD5<sup>lo</sup> cells - recent studies
using <italic>Cd5</italic><sup>&#x02212;/&#x02212;</sup> mice do not support that
concept<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>, although this does not negate the value of CD5 expression level as a
marker. As we show here, the CD5<sup>hi</sup> population differs from CD5<sup>lo</sup> cells
in their expression of several genes. However, even within the CD5<sup>hi</sup> pool there
is heterogeneity in T-bet, CXCR3 and induced XCL1 expression &#x02013; hence there may be
other features of CD5<sup>hi</sup> cells that better correlate with their improved
functional prowess. We found a modest but significant advantage of CXCR3<sup>hi</sup>
CD5<sup>hi</sup> over CXCR3<sup>lo</sup> CD5<sup>hi</sup> populations, suggesting CXCR3
expression may be a core feature of the optimal foreign antigen reactivity by
CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cells.</p><p id="P33">Together, these findings suggest that na&#x000ef;ve CD8<sup>+</sup> T
cells with the greatest level of self-reactivity are the most efficiently recruited into the
foreign-pMHC specific response. Since sensitivity to TCR signals may change following
na&#x000ef;ve T cell activation, it is possible that progeny of some CD5<sup>hi</sup> clones
could exhibit overt self-reactivity following activation, with significance for the
induction of autoimmune disease following response to infection. At the same time, our
findings leave open the question of why the CD5<sup>lo</sup> pool is maintained in the
na&#x000ef;ve CD8<sup>+</sup> T cell repertoire. CD5<sup>lo</sup> cells are
relatively resistant to deprivation of IL-7<sup><xref rid="R26" ref-type="bibr">26</xref></sup>, making it possible that these cells are efficiently maintained during
na&#x000ef;ve T cell competition for homeostatic cytokines. Alternatively, CD5<sup>lo</sup>
na&#x000ef;ve CD8<sup>+</sup> T cells may show superior responses to pathogens in
certain situations: as shown for na&#x000ef;ve CD4<sup>+</sup> T cells heightened
initial reactivity may accompany increased sensitivity to cell death<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R11" ref-type="bibr">11</xref></sup>. Whether some
immune responses favor the CD5<sup>lo</sup> population of na&#x000ef;ve
CD8<sup>+</sup> T cells awaits further investigation.</p></sec><sec sec-type="methods" id="S10" specific-use="web-only"><title>METHODS</title><sec id="S11"><title>Mice</title><p id="P34">We purchased 6- to 12-week-old female C57BL/6 and B6.SJL mice from the National
Cancer Institute. For adoptive cell transfer recipients, we used F1 CD45.1/2 females
generated from C57BL/6J (Jackson Laboratories) crossed with B6.SJL (NCI) mice.
<italic>Il15</italic><sup>&#x02212;/&#x02212;</sup> and TCR-transgenic P14
mice<sup><xref rid="R51" ref-type="bibr">51</xref></sup> were kind gifts from D.
Masopust (University of Minnesota, Minneapolis, MN). P14 and OT-I<sup><xref rid="R52" ref-type="bibr">52</xref></sup> and were maintained on a C57BL/6N and B6.PL (Thy-1.1)
backgrounds. HY TCR transgenic mice were maintained on a
<italic>Rag2</italic><sup>&#x02212;/&#x02212;</sup> background (apart from initial cell
surface phenotype studies, in which cells from female
<italic>Rag2</italic><sup>+/+</sup> HY mice were analyzed with the T3.70
monoclonal antibody to identify HY-specific CD8<sup>+</sup> T cells). F5
<italic>Rag1</italic><sup>&#x02212;/&#x02212;</sup> mice were a kind gift of L. Cauley
(University of Connecticut) and <italic>Cd25</italic><sup>&#x02212;/&#x02212;</sup> mice
were obtained from Jackson Labs. The Nur77<sup>gfp</sup> transgenic reporter mice have
been previously described<sup><xref rid="R30" ref-type="bibr">30</xref></sup>, and were
maintained on a C57BL/6N background. T-bet&#x02013;ZsGreen reporter mice<sup><xref rid="R50" ref-type="bibr">50</xref></sup> were initially obtained from J. Zhu (US
National Institute of Allergy and Infectious Diseases, Bethesda, MD), and maintained on
the C57BL/6N background. All mice were maintained in SPF conditions, and all mouse
protocols were approved by the University of Minnesota Institutional Animal Care and Use
Committee. No samples/animals were excluded from the analysis. The investigators were not
blinded to group allocations or assessment.</p></sec><sec id="S12"><title>Bacterial and Viral Infections</title><p id="P35">&#x00394;ActA attenuated LM (DP-L1942)<sup><xref rid="R53" ref-type="bibr">53</xref></sup> and &#x00394;ActA LM-OVA were provided by J. Harty (University of
Iowa, Iowa City, IA) and LM-B8R (both virulent and &#x00394;ActA), which contains both the
K<sup>b</sup>-restricted CD8<sup>+</sup> epitopes B8R<sub>20&#x02013;27</sub>
and OVA<sub>257&#x02013;264</sub> was a kind gift of R. Kedl (National Jewish Medical
Research Center, University of Colorado, Denver, CO). LCMV Armstrong was a gift of D.
Masopust. LM was grown in tryptic soy broth containing 50 &#x003bc;g/mL streptomycin to an
OD<sub>600</sub> of ~0.1. For primary infection with attenuated LM-B8R, 3 &#x000d7;
10<sup>6</sup> CFU were injected intravenously (i.v.). For secondary infections with
virulent LM-B8R, mice were injected with 1 &#x000d7;10<sup>6</sup> CFU i.v. In experiments
where wild-type &#x00394;ActA LM was used to induce inflammation, 3&#x02013;6 &#x000d7;
10<sup>6</sup> CFU bacteria were mixed with peptide-pulsed DCs and co-injected i.v. For
LCMV infections, mice were injected with 2 &#x000d7; 10<sup>5</sup> PFU
intraperitoneally.</p></sec><sec id="S13"><title>Dendritic Cell Immunizations</title><p id="P36">Splenic DCs were prepared as previously described<sup><xref rid="R49" ref-type="bibr">49</xref></sup>. Briefly, to generate splenic DCs, mice were injected
s.c. with 5 &#x000d7; 10<sup>6</sup> B16 cells expressing Flt3L (provided by M. Prlic and
M. Bevan, University of Washington, Seattle, via J. Harty, University of Iowa). When
tumors were palpable (5 &#x000d7; 5 mm), mice were injected with 2 &#x003bc;g LPS i.v. to
mature the DCs and spleens were harvested ~16 h later. Following digestion with
collagenase D for 20 min at 37&#x000b0;C, RBCs were lysed and splenocytes were resuspended
in media comprised of 2 parts complete RPMI, 1 part B16-Flt3L-conditioned complete RPMI,
50 ng/mL GM-CSF, and 2 &#x003bc;M peptide. The C2A mutant of the SMCY peptide<sup><xref rid="R54" ref-type="bibr">54</xref></sup> was used to stimulate HY
CD8<sup>+</sup> T cells, while OVA<sub>257&#x02013;264</sub> was used for
stimulation of OT-I. Splenocytes were pulsed with peptide for 2 h at 37 &#x000b0;C,
thoroughly washed, and DCs purified using Miltenyi CD11c microbeads. Mice were co-injected
i.v. with 1 &#x000d7; 10<sup>6</sup> DCs pulsed with each peptide, with co-administration
of LM, LCMV or CpG as indicated.</p></sec><sec id="S14"><title>Flow Cytometry</title><p id="P37">Cells were stained with the following antibodies from eBioscience or BD
Biosciences unless otherwise noted: CD4 (RM4-5), CD8<sup>+</sup> (53&#x02013;6.7),
CD5 (53&#x02013;7.3), CD27 (LG.7F9), CD44 (IM7), CD45.1 (A20), CD45.2 (104), Thy1.1 (HIS51
or OX-7), Thy1.2 (53&#x02013;2.1), CD62L (MEL-14), CD69 (H1.2F3), CD122 (TM-b1), CD127
(A7R34), TCR&#x003b2; (H57-597), CXCR3 (CXCR3-173), IFN-&#x003b3; (XMG1.2), MHC class II
(M5/114.15.2), and F4/80 (BM8). The B8R/K<sup>b</sup> and OVA/K<sup>b</sup> tetramers were
generated as previously described<sup><xref rid="R43" ref-type="bibr">43</xref></sup>. The
MCMV M57/K<sup>b</sup>, LCMV gp33/D<sup>b</sup>, influenza NP68/D<sup>b</sup>, and HY
SMCY/D<sup>b</sup> tetramers were provided by the NIH Tetramer Facility. For
intracellular staining of transcription factors, cells were fixed and permeabilized with
Foxp3 Fixation and Permeabilization Buffers (eBioscience) and stained with antibodies to
T-bet (4B10) and Eomesodermin (Dan11mag) in Permeabilization Solution. Data was collected
on LSR-II or Fortessa flow cytometers (BD Biosciences) and data were analyzed by using
FlowJo analysis software (Tree Star).</p></sec><sec id="S15"><title>XCL1 expression assay</title><p id="P38">Peripheral lymphocytes were stained with anti-XCL1 mAb (MTAC-2)<sup><xref rid="R55" ref-type="bibr">55</xref></sup> that was kindly provided by R. Kroczek
(Robert Koch-Institute, Berlin, Germany). To examine XCL1 production, bulk splenocytes
were stimulated to PMA/ionomycin for 3&#x02013;5 h at 37&#x000b0;C in the presence of
Brefeldin A. Cells were stained for cell surface markers then fixed and permeabilized with
BD Cytofix/Cytoperm or eBiosciences Foxp3/transcription factor fixation/permeabilization
solutions, prior to intracellular staining for XCL1.</p></sec><sec id="S16"><title>Cell Sorting and Adoptive Transfer</title><p id="P39">For adoptive transfer experiments, spleens and lymph nodes from C57BL/6
(CD45.2/2) and B6.SJL (CD45.1/1) mice digested with collagenase D (Roche) and negatively
enriched for CD8<sup>+</sup> T cells using Miltenyi enrichment antibody cocktail
and beads. Cells were then stained with anti-CD8, CD5, and CD44 and
CD8<sup>+</sup>CD44<sup>lo</sup> cells (i.e. excluding CD44<sup>hi</sup> cells)
were sorted on the lower or upper 20% of CD5 expression using a BD FACSAria I. In
some studies, the CD5<sup>hi</sup> CD44<sup>lo</sup> population was further gated on the
lower or upper 30% of CXCR3 prior to sorting. Approximately 1.25&#x02013;1.5
&#x000d7; 10<sup>6</sup> each of congenically mismatched CD5<sup>lo</sup> and
CD5<sup>hi</sup> cells were co-transferred into CD45.1/2 recipients and infected with
LM-B8R in the next day. For recall experiments, CD5<sup>lo/hi</sup> recipients that had
been infected with &#x00394;ActA LM-B8R &#x0003e;40 days previous were challenged with virulent
LM-B8R. Varied combinations of congenic backgrounds for donor and host animals in transfer
studies.</p><p id="P40">In experiments where we transferred single B8R/K<sup>b</sup>-specific
CD8<sup>+</sup> T cell clones, CD8<sup>+</sup> T cells were negative
enriched from the spleens and lymph node cells of 4 to 8 congenically distinct donors by
using different combinations of CD45.1/2 and CD90.1/2 (<xref rid="SD1" ref-type="supplementary-material">Supplementary Fig. 6</xref>). Equal numbers of
CD8<sup>+</sup> T cells from each congenic donor group were mixed, stained with
anti-CD8, CD5, and CD44 and sorted for na&#x000ef;ve CD8<sup>+</sup> T cells in
the lower or upper 20% for CD5 expression. The indicated number of
CD5<sup>lo/hi</sup> cells for each congenic group was then transferred into congenic
recipients. Mice were infected 1&#x02013;2 days post-transfer with attenuated LM-B8R, and
the response to B8R/K<sup>b</sup> was assessed 7 days later. Background staining for
congenic markers was very low (1 event or less, data not shown), and we set our limit of
detection at &#x02265;3 flow cytometric events in the antigen specific population, which
equates to ~5 total B8R/K<sup>b</sup> specific CD8<sup>+</sup> T cells</p><p id="P41">In adoptive transfer experiments using TCR transgenic CD8<sup>+</sup> T
cells, CD44<sup>lo</sup> Thy-1.1 OT-I cells (RAG<sup>+/+</sup> or
RAG-1<sup>&#x02212;/&#x02212;</sup>) were enriched by negative selection as previously
described<sup><xref rid="R56" ref-type="bibr">56</xref></sup>. Female
<italic>Rag-2</italic><sup>&#x02212;/&#x02212;</sup> HY CD8<sup>+</sup> T cells,
which are all CD44<sup>lo</sup>, were negatively enriched using Miltenyi beads. Mixtures
containing 1000 each of the OT-I and HY populations were co-transferred i.v. into B6.SJL
mice and these recipients were immunized 1 day later. To assess the
&#x0201c;take&#x0201d;, 2 &#x000d7; 10<sup>5</sup> cells from the same mixture of OT-I and
HY cells was transferred into recipients, cells from these mice were then analyzed by flow
cytometry the day of immunization. Similar &#x0201c;take&#x0201d; ratios were observed
when animals receiving 1000 OT-I and HY T cells were enriched using magnetic beads on the
day of immunization (data not shown).</p></sec><sec id="S17"><title>MHC Class I Tetramer Enrichment</title><p id="P42">To analyze CD8<sup>+</sup> T cell antigen-specific precursors or
CD5<sup>lo/hi</sup> donor responses following infection, MHC class I tetramer enrichment
was used as previously described<sup><xref rid="R35" ref-type="bibr">35</xref></sup>.
Briefly, spleen and lymph nodes (for analyzing precursors) or spleen only (LM infection)
were digested with collagenase D. Cells were labeled with PE- or APC-conjugated tetramers
and enriched over magnetic columns using anti-PE or APC magnetic beads (Miltenyi). A small
portion of the enriched fraction was added to AccuCheck counting beads (Invitrogen) to
accurately back-calculate total numbers. Tetramer-enriched fractions were then stained
with additional extracellular antibodies and fixed with paraformaldehyde prior to analysis
by flow cytometry.</p></sec><sec id="S18"><title>Mixed Bone-Marrow Chimeras</title><p id="P43">We generated mixed bone-marrow chimeras by mixing T cell-depleted bone marrow
from congenic strains and injecting 5&#x02013;10 &#x000d7; 10<sup>6</sup> cells into
lethally irradiated (1000 rads) host animals. For chimeras with WT and
<italic>Cd25</italic><sup>&#x02212;/&#x02212;</sup> bone marrow, roughly equal numbers
of cells from CD45.1/2<sup>+</sup> WT and CD45.2<sup>+</sup>
<italic>Cd25</italic><sup>&#x02212;/&#x02212;</sup> mice (6&#x02013;8 weeks of age) were
injected into CD45.1<sup>+</sup> WT hosts. For OT-I chimeras, Thy-disparate OT-I
(RAG<sup>+</sup>) bone marrow was injected into congenically distinct WT or
<italic>&#x003b2;2m</italic><sup>&#x02212;/&#x02212;</sup> recipients. Cells from
chimeras were used &#x0003e;10 weeks after transplant.</p></sec><sec id="S19"><title><italic>In vitro</italic> Stimulation</title><p id="P44">To assess CD8<sup>+</sup> T cell activation, 2&#x000d7;10<sup>4</sup>
purified CD44<sup>lo</sup> CD8<sup>+</sup> TCR transgenic cells were incubated at
37&#x000b0;C with 1&#x02013;2&#x000d7;10<sup>6</sup> splenic antigen presenting cells in
96-well round-bottom plates with titrated doses of cognate peptide: OT-I with
K<sup>b</sup>/OVA<sub>257&#x02013;264</sub> (SIINFEKL), P14 with
D<sup>b</sup>/gp<sub>33&#x02013;41</sub> (KAVYNFATC), F5 with
D<sup>b</sup>/NP<sub>366&#x02013;374</sub> (ASNENMDAM), HY with D<sup>b</sup>/Smcy
(KCSRNRQYL) or D<sup>b</sup>/C2A (KASRNRQYL). Cells were stimulated for 6 h and then
stained for CD69 expression.</p></sec><sec id="S20"><title>RMA-S MHC Class I Stabilization Assay</title><p id="P45">RMA-S cells were cultured in RPMI containing 10% FCS at 30&#x000b0;C
with 5% CO<sub>2</sub> overnight. In a 96-well round-bottom plate 1 &#x000d7;
10<sup>5</sup> RMA-S cells were incubated with titrated doses of peptide for 1 h and
then the plate was moved to a 37 &#x000b0;C CO<sub>2</sub> incubator for 3 h. Cells were
then stained for stable surface class I molecules using H-2K<sup>b</sup> (Y3) or
H-2D<sup>b</sup> (28.14.8) antibodies.</p></sec><sec id="S21"><title>Gene Transcription Analysis</title><p id="P46">Na&#x000ef;ve CD44<sup>lo</sup> CD8<sup>+</sup> T cells from spleens and
lymph nodes were flow sorted on the lower and upper 20% of CD5 expression as
described above. For each sample &#x02265;1 &#x000d7; 10<sup>6</sup> cells were used for
RNA extraction using a RNeasy microkit (Qiagen). RNA was used to generate biotinylated
cRNA using the MessageAmpIII RNA Amplification kit (Ambion) following the
manufacturer&#x02019;s recommendations. Samples were hybridized to Affymetrix murine 430
2.0 gene chips at the BioMedical Genomics Center (University of Minnesota) following
standard procedures. RNA samples from three independent sorts were analyzed. Gene
expression analysis that led to <xref rid="T1" ref-type="table">Table 1</xref> used
Genespring software: Data were MAS5 normalized and filtered for present/absent calls in at
least one group, and for stastically significant (<italic>P</italic> &#x0003c; 0.05) fold
change of &#x0003e;2.0. For enrichment analysis (<xref rid="T2" ref-type="table">Table
2</xref>), cluster genes expressed by either CD5<sup>hi</sup> or CD5<sup>lo</sup> cells
were determined to be any genes with a Fold Change (FC)&#x0003e;0. Significance was determined
by &#x003c7;<sup>2</sup> where equal distribution was taken as the null hypothesis.
Histograms show fold change within the CD5<sup>hi</sup> versus CD5<sup>lo</sup>
comparison, binned as indicated, for genes within the indicated clusters.</p></sec><sec id="S22" sec-type="results"><title>Statistics</title><p id="P47">Unless indicated otherwise in the figure legend, a two-tailed, unpaired
Student&#x02019;s <italic>t</italic> test was performed on log-transformed data using
Prism (GraphPad Software). When making multiple comparisons, one-way ANOVA with
Dunnett&#x02019;s Multiple Comparison post-test was used. Sample sizes were chosen based
on previous experience and similar studies. In the clonal analysis shown in <xref rid="F4" ref-type="fig">Fig. 4</xref>, the data distribution was not normal or lognormal, and the
non-parametric Mann-Whitney test was applied. The <italic>P</italic> values are indicated
with asterisks, defined in each figure legend.</p></sec></sec><sec sec-type="supplementary-material" id="S23"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS638367-supplement-1.docx" orientation="portrait" xlink:type="simple" id="d37e2576" position="anchor"/></supplementary-material></sec></body><back><ack id="S24"><p>We thank the University of Minnesota Flow Core personnel for flow cytometry support and
cell sorting. We thank M. Jenkins and M. Mescher for critical review of the manuscript, G.
Stritesky for insight on analysis of Nur77 mice, J. Ding and S. Peery for excellent
technical assistance with mice and members of the Jamequist laboratory provided valuable
discussions throughout. We also thank R. Kroczek (Robert Koch-Institute, Berlin, Germany)
for generously providing conjugated MTAC-2 antibody. The authors declare no financial
interests. This work was supported by NIH award R37 AI-38903 (S.C.J.) and the Irvington
Institute Fellowship Program of the Cancer Research Institute (R.B.F.). <italic>Research
reported in this publication was also supported by NIH grant P30 CA77598 utilizing the
Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center,
University of Minnesota and by the by the National Center for Advancing Translational
Sciences of the National Institutes of Health Award Number UL1TR000114. The content is
solely the responsibility of the authors and does not necessarily represent the official
views of the National Institutes of Health.</italic></p></ack><fn-group><fn id="FN2"><p><bold>Accession codes.</bold> GEO: microarray data, GSE62142.</p></fn><fn id="FN3" fn-type="con"><p><bold>AUTHOR CONTRIBUTIONS</bold></p><p>R.B.F. and S.C.J. designed the experimental approaches; R.B.F. and S.E.H. conducted
experiments; Y.X. and K.A.H. provided mouse strains and bone marrow chimeras; J.A.B. and
A.W.G. analyzed gene expression data; R.B.F. and S.C.J. wrote and edited the
manuscript.</p></fn><fn id="FN4" fn-type="conflict"><p><bold>COMPETING FINANCIAL INTERESTS</bold></p><p>None</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zehn</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Bevan</surname><given-names>MJ</given-names></name></person-group><article-title>Complete but curtailed T-cell response to very low-affinity
antigen</article-title><source>Nature</source><volume>458</volume><fpage>211</fpage><lpage>214</lpage><year>2009</year><pub-id pub-id-type="pmid">19182777</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tubo</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Single Naive CD4(+) T Cells from a Diverse Repertoire Produce
Different Effector Cell Types during Infection</article-title><source>Cell</source><volume>153</volume><fpage>785</fpage><lpage>796</lpage><year>2013</year><pub-id pub-id-type="pmid">23663778</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazilleau</surname><given-names>N</given-names></name><name><surname>McHeyzer-Williams</surname><given-names>LJ</given-names></name><name><surname>Rosen</surname><given-names>H</given-names></name><name><surname>McHeyzer-Williams</surname><given-names>MG</given-names></name></person-group><article-title>The function of follicular helper T cells is regulated by the strength of T
cell antigen receptor binding</article-title><source>Nature immunology</source><volume>10</volume><fpage>375</fpage><lpage>384</lpage><year>2009</year><pub-id pub-id-type="pmid">19252493</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plumlee</surname><given-names>CR</given-names></name><name><surname>Sheridan</surname><given-names>BS</given-names></name><name><surname>Cicek</surname><given-names>BB</given-names></name><name><surname>Lefrancois</surname><given-names>L</given-names></name></person-group><article-title>Environmental cues dictate the fate of individual CD8(+) T cells
responding to infection</article-title><source>Immunity</source><volume>39</volume><fpage>347</fpage><lpage>356</lpage><year>2013</year><pub-id pub-id-type="pmid">23932571</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorfman</surname><given-names>JR</given-names></name><name><surname>Stefanova</surname><given-names>I</given-names></name><name><surname>Yasutomo</surname><given-names>K</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name></person-group><article-title>CD4+ T cell survival is not directly linked to self-MHC-induced TCR
signaling</article-title><source>Nature immunology</source><volume>1</volume><fpage>329</fpage><lpage>335</lpage><year>2000</year><pub-id pub-id-type="pmid">11017105</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stefanova</surname><given-names>I</given-names></name><name><surname>Dorfman</surname><given-names>JR</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name></person-group><article-title>Self-recognition promotes the foreign antigen sensitivity of naive T
lymphocytes</article-title><source>Nature</source><volume>420</volume><fpage>429</fpage><lpage>434</lpage><year>2002</year><pub-id pub-id-type="pmid">12459785</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhandoola</surname><given-names>A</given-names></name><etal/></person-group><article-title>Peripheral expression of self-MHC-II influences the reactivity and
self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell
model</article-title><source>Immunity</source><volume>17</volume><fpage>425</fpage><lpage>436</lpage><year>2002</year><pub-id pub-id-type="pmid">12387737</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochweller</surname><given-names>K</given-names></name><etal/></person-group><article-title>Dendritic cells control T cell tonic signaling required for responsiveness
to foreign antigen</article-title><source>Proc Natl Acad Sci U S A</source><volume>107</volume><fpage>5931</fpage><lpage>5936</lpage><year>2010</year><pub-id pub-id-type="pmid">20231464</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandl</surname><given-names>JN</given-names></name><name><surname>Monteiro</surname><given-names>JP</given-names></name><name><surname>Vrisekoop</surname><given-names>N</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name></person-group><article-title>T cell-positive selection uses self-ligand binding strength to optimize
repertoire recognition of foreign antigens</article-title><source>Immunity</source><volume>38</volume><fpage>263</fpage><lpage>274</lpage><year>2013</year><pub-id pub-id-type="pmid">23290521</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Distinct CD4+ helper T cells involved in primary and secondary
responses to infection</article-title><source>Proceedings of the National Academy of Sciences of the United States of
America</source><volume>109</volume><fpage>9511</fpage><lpage>9516</lpage><year>2012</year><pub-id pub-id-type="pmid">22645349</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persaud</surname><given-names>SP</given-names></name><name><surname>Parker</surname><given-names>CR</given-names></name><name><surname>Lo</surname><given-names>WL</given-names></name><name><surname>Weber</surname><given-names>KS</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name></person-group><article-title>Intrinsic CD4 T cell sensitivity and response to a pathogen are set and
sustained by avidity for thymic and peripheral complexes of self peptide and
MHC</article-title><source>Nature immunology</source><year>2014</year></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starr</surname><given-names>TK</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name></person-group><article-title>Positive and negative selection of T cells</article-title><source>Annu Rev Immunol</source><volume>21</volume><fpage>139</fpage><lpage>176</lpage><year>2003</year><pub-id pub-id-type="pmid">12414722</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanchot</surname><given-names>C</given-names></name><name><surname>Lemonnier</surname><given-names>FA</given-names></name><name><surname>Perarnau</surname><given-names>B</given-names></name><name><surname>Freitas</surname><given-names>AA</given-names></name><name><surname>Rocha</surname><given-names>B</given-names></name></person-group><article-title>Differential requirements for survival and proliferation of CD8 naive or
memory T cells</article-title><source>Science</source><volume>276</volume><fpage>2057</fpage><lpage>2062</lpage><year>1997</year><pub-id pub-id-type="pmid">9197272</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>K</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><article-title>Self-class I MHC molecules support survival of naive CD8 T cells, but
depress their functional sensitivity through regulation of CD8 expression
levels</article-title><source>J Exp Med</source><volume>206</volume><fpage>2253</fpage><lpage>2269</lpage><year>2009</year><pub-id pub-id-type="pmid">19752186</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>K</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><article-title>Naive T cell homeostasis: from awareness of space to a sense of
place</article-title><source>Nat Rev Immunol</source><volume>9</volume><fpage>823</fpage><lpage>832</lpage><year>2009</year><pub-id pub-id-type="pmid">19935802</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprent</surname><given-names>J</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name></person-group><article-title>Normal T cell homeostasis: the conversion of naive cells into
memory-phenotype cells</article-title><source>Nat Immunol</source><volume>12</volume><fpage>478</fpage><lpage>484</lpage><year>2011</year><pub-id pub-id-type="pmid">21739670</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarakhovsky</surname><given-names>A</given-names></name><etal/></person-group><article-title>A role for CD5 in TCR-mediated signal transduction and thymocyte
selection</article-title><source>Science</source><volume>269</volume><fpage>535</fpage><lpage>537</lpage><year>1995</year><pub-id pub-id-type="pmid">7542801</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azzam</surname><given-names>HS</given-names></name><etal/></person-group><article-title>CD5 expression is developmentally regulated by T cell receptor (TCR)
signals and TCR avidity</article-title><source>J Exp Med</source><volume>188</volume><fpage>2301</fpage><lpage>2311</lpage><year>1998</year><pub-id pub-id-type="pmid">9858516</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>P</given-names></name><name><surname>Barton</surname><given-names>GM</given-names></name><name><surname>Forbush</surname><given-names>KA</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name></person-group><article-title>Dynamic tuning of T cell reactivity by self-peptide-major
histocompatibility complex ligands</article-title><source>J Exp Med</source><volume>193</volume><fpage>1179</fpage><lpage>1187</lpage><year>2001</year><pub-id pub-id-type="pmid">11369789</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K</given-names></name><etal/></person-group><article-title>Sensory adaptation in naive peripheral CD4 T cells</article-title><source>J Exp Med</source><volume>194</volume><fpage>1253</fpage><lpage>1261</lpage><year>2001</year><pub-id pub-id-type="pmid">11696591</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>B</given-names></name><name><surname>Zamoyska</surname><given-names>R</given-names></name></person-group><article-title>TCR signals mediated by Src family kinases are essential for the survival
of naive T cells</article-title><source>J Immunol</source><volume>169</volume><fpage>2997</fpage><lpage>3005</lpage><year>2002</year><pub-id pub-id-type="pmid">12218114</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieper</surname><given-names>WC</given-names></name><name><surname>Burghardt</surname><given-names>JT</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name></person-group><article-title>A role for TCR affinity in regulating naive T cell
homeostasis</article-title><source>J Immunol</source><volume>172</volume><fpage>40</fpage><lpage>44</lpage><year>2004</year><pub-id pub-id-type="pmid">14688307</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>Q</given-names></name><name><surname>Bai</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>B</given-names></name><name><surname>Eisen</surname><given-names>HN</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Competition for self-peptide-MHC complexes and cytokines between naive and
memory CD8+ T cells expressing the same or different T cell
receptors</article-title><source>Proceedings of the National Academy of Sciences of the United States of
America</source><volume>101</volume><fpage>3041</fpage><lpage>3046</lpage><year>2004</year><pub-id pub-id-type="pmid">14976256</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>HO</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name></person-group><article-title>T cell receptor-dependent regulation of lipid rafts controls naive
CD8<sup>+</sup> T cell homeostasis</article-title><source>Immunity</source><volume>32</volume><fpage>214</fpage><lpage>226</lpage><year>2010</year><pub-id pub-id-type="pmid">20137986</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>LD</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><article-title>Self-specific CD8+ T cells maintain a semi-naive state following
lymphopenia-induced proliferation</article-title><source>J Immunol</source><volume>184</volume><fpage>5604</fpage><lpage>5611</lpage><year>2010</year><pub-id pub-id-type="pmid">20393139</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>MJ</given-names></name><name><surname>Mahajan</surname><given-names>VS</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Irvine</surname><given-names>DJ</given-names></name><name><surname>Lauffenburger</surname><given-names>DA</given-names></name></person-group><article-title>Signaling thresholds govern heterogeneity in IL-7-receptor-mediated
responses of naive CD8<sup>+</sup> T cells</article-title><source>Immunology and cell biology</source><volume>89</volume><fpage>581</fpage><lpage>594</lpage><year>2011</year><pub-id pub-id-type="pmid">21339767</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JH</given-names></name><etal/></person-group><article-title>&#x02018;Coreceptor tuning&#x02019;: cytokine signals transcriptionally
tailor CD8 coreceptor expression to the self-specificity of the TCR</article-title><source>Nat Immunol</source><volume>8</volume><fpage>1049</fpage><lpage>1059</lpage><year>2007</year><pub-id pub-id-type="pmid">17873878</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaech</surname><given-names>SM</given-names></name><name><surname>Cui</surname><given-names>W</given-names></name></person-group><article-title>Transcriptional control of effector and memory CD8+ T cell
differentiation</article-title><source>Nature reviews. Immunology</source><volume>12</volume><fpage>749</fpage><lpage>761</lpage><year>2012</year></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judge</surname><given-names>AD</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Fujii</surname><given-names>H</given-names></name><name><surname>Surh</surname><given-names>CD</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name></person-group><article-title>Interleukin 15 controls both proliferation and survival of a subset of
memory-phenotype CD8(+) T cells</article-title><source>J Exp Med</source><volume>196</volume><fpage>935</fpage><lpage>946</lpage><year>2002</year><pub-id pub-id-type="pmid">12370255</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>AE</given-names></name><etal/></person-group><article-title>T cell receptor signal strength in Treg and iNKT cell development
demonstrated by a novel fluorescent reporter mouse</article-title><source>J Exp Med</source><volume>208</volume><fpage>1279</fpage><lpage>1289</lpage><year>2011</year><pub-id pub-id-type="pmid">21606508</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Asymmetric Proteasome Segregation as a Mechanism for Unequal Partitioning
of the Transcription Factor T-bet during T Lymphocyte Division</article-title><source>Immunity</source><volume>34</volume><fpage>492</fpage><lpage>504</lpage><year>2011</year><pub-id pub-id-type="pmid">21497118</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>AT</given-names></name><name><surname>Wilcox</surname><given-names>HM</given-names></name><name><surname>Lai</surname><given-names>Z</given-names></name><name><surname>Berg</surname><given-names>LJ</given-names></name></person-group><article-title>Signaling through Itk promotes T helper 2 differentiation via negative
regulation of T-bet</article-title><source>Immunity</source><volume>21</volume><fpage>67</fpage><lpage>80</lpage><year>2004</year><pub-id pub-id-type="pmid">15345221</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorner</surname><given-names>BG</given-names></name><etal/></person-group><article-title>Selective expression of the chemokine receptor XCR1 on cross-presenting
dendritic cells determines cooperation with CD8+ T cells</article-title><source>Immunity</source><volume>31</volume><fpage>823</fpage><lpage>833</lpage><year>2009</year><pub-id pub-id-type="pmid">19913446</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Best</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Transcriptional insights into the CD8(+) T cell response to
infection and memory T cell formation</article-title><source>Nature immunology</source><volume>14</volume><fpage>404</fpage><lpage>412</lpage><year>2013</year><pub-id pub-id-type="pmid">23396170</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haluszczak</surname><given-names>C</given-names></name><etal/></person-group><article-title>The antigen-specific CD8+ T cell repertoire in unimmunized mice
includes memory phenotype cells bearing markers of homeostatic expansion</article-title><source>J Exp Med</source><volume>206</volume><fpage>435</fpage><lpage>448</lpage><year>2009</year><pub-id pub-id-type="pmid">19188498</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Chemokine guidance of central memory T cells is critical for antiviral
recall responses in lymph nodes</article-title><source>Cell</source><volume>150</volume><fpage>1249</fpage><lpage>1263</lpage><year>2012</year><pub-id pub-id-type="pmid">22980984</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastenmuller</surname><given-names>W</given-names></name><etal/></person-group><article-title>Peripheral prepositioning and local CXCL9 chemokine-mediated guidance
orchestrate rapid memory CD8+ T cell responses in the lymph node</article-title><source>Immunity</source><volume>38</volume><fpage>502</fpage><lpage>513</lpage><year>2013</year><pub-id pub-id-type="pmid">23352234</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starbeck-Miller</surname><given-names>GR</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><article-title>IL-12 and type I interferon prolong the division of activated CD8 T cells
by maintaining high-affinity IL-2 signaling in vivo</article-title><source>J Exp Med</source><volume>211</volume><fpage>105</fpage><lpage>120</lpage><year>2013</year><pub-id pub-id-type="pmid">24367005</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malek</surname><given-names>TR</given-names></name><name><surname>Castro</surname><given-names>I</given-names></name></person-group><article-title>Interleukin-2 receptor signaling: at the interface between tolerance and
immunity</article-title><source>Immunity</source><volume>33</volume><fpage>153</fpage><lpage>165</lpage><year>2010</year><pub-id pub-id-type="pmid">20732639</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchholz</surname><given-names>VR</given-names></name><etal/></person-group><article-title>Disparate individual fates compose robust CD8+ T cell
immunity</article-title><source>Science</source><volume>340</volume><fpage>630</fpage><lpage>635</lpage><year>2013</year><pub-id pub-id-type="pmid">23493420</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerlach</surname><given-names>C</given-names></name><etal/></person-group><article-title>Heterogeneous differentiation patterns of individual CD8+ T
cells</article-title><source>Science</source><volume>340</volume><fpage>635</fpage><lpage>639</lpage><year>2013</year><pub-id pub-id-type="pmid">23493421</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Heijst</surname><given-names>JW</given-names></name><etal/></person-group><article-title>Recruitment of antigen-specific CD8+ T cells in response to
infection is markedly efficient</article-title><source>Science</source><volume>325</volume><fpage>1265</fpage><lpage>1269</lpage><year>2009</year><pub-id pub-id-type="pmid">19729659</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>MA</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><article-title>Critical role for CD8 in T cell receptor binding and activation by
peptide/major histocompatibility complex multimers</article-title><source>J Exp Med</source><volume>191</volume><fpage>335</fpage><lpage>346</lpage><year>2000</year><pub-id pub-id-type="pmid">10637277</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haring</surname><given-names>JS</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><article-title>Inflaming the CD8+ T cell response</article-title><source>Immunity</source><volume>25</volume><fpage>19</fpage><lpage>29</lpage><year>2006</year><pub-id pub-id-type="pmid">16860754</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>W</given-names></name><name><surname>Kaech</surname><given-names>SM</given-names></name></person-group><article-title>Generation of effector CD8+ T cells and their conversion to memory
T cells</article-title><source>Immunological reviews</source><volume>236</volume><fpage>151</fpage><lpage>166</lpage><year>2010</year><pub-id pub-id-type="pmid">20636815</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Messingham</surname><given-names>KA</given-names></name><name><surname>Jabbari</surname><given-names>A</given-names></name><name><surname>Haring</surname><given-names>JS</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><article-title>Accelerated CD8+ T-cell memory and prime-boost response after
dendritic-cell vaccination</article-title><source>Nat Med</source><volume>11</volume><fpage>748</fpage><lpage>756</lpage><year>2005</year><pub-id pub-id-type="pmid">15951824</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtsinger</surname><given-names>JM</given-names></name><name><surname>Mescher</surname><given-names>MF</given-names></name></person-group><article-title>Inflammatory cytokines as a third signal for T cell
activation</article-title><source>Curr Opin Immunol</source><volume>22</volume><fpage>333</fpage><lpage>340</lpage><year>2010</year><pub-id pub-id-type="pmid">20363604</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maile</surname><given-names>R</given-names></name><etal/></person-group><article-title>Peripheral &#x0201c;CD8 tuning&#x0201d; dynamically modulates the size and
responsiveness of an antigen-specific T cell pool in vivo</article-title><source>Journal of immunology</source><volume>174</volume><fpage>619</fpage><lpage>627</lpage><year>2005</year></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pham</surname><given-names>NL</given-names></name><name><surname>Badovinac</surname><given-names>VP</given-names></name><name><surname>Harty</surname><given-names>JT</given-names></name></person-group><article-title>A default pathway of memory CD8 T cell differentiation after dendritic cell
immunization is deflected by encounter with inflammatory cytokines during antigen-driven
proliferation</article-title><source>J Immunol</source><volume>183</volume><fpage>2337</fpage><lpage>2348</lpage><year>2009</year><pub-id pub-id-type="pmid">19635915</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title>The transcription factor T-bet is induced by multiple pathways and prevents
an endogenous Th2 cell program during Th1 cell responses</article-title><source>Immunity</source><volume>37</volume><fpage>660</fpage><lpage>673</lpage><year>2012</year><pub-id pub-id-type="pmid">23041064</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pircher</surname><given-names>H</given-names></name><name><surname>Rohrer</surname><given-names>UH</given-names></name><name><surname>Moskophidis</surname><given-names>D</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name><name><surname>Hengartner</surname><given-names>H</given-names></name></person-group><article-title>Lower receptor avidity required for thymic clonal deletion than for
effector T-cell function</article-title><source>Nature</source><volume>351</volume><fpage>482</fpage><lpage>485</lpage><year>1991</year><pub-id pub-id-type="pmid">1710780</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogquist</surname><given-names>KA</given-names></name><etal/></person-group><article-title>T cell receptor antagonist peptides induce positive
selection</article-title><source>Cell</source><volume>76</volume><fpage>17</fpage><lpage>27</lpage><year>1994</year><pub-id pub-id-type="pmid">8287475</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brundage</surname><given-names>RA</given-names></name><name><surname>Smith</surname><given-names>GA</given-names></name><name><surname>Camilli</surname><given-names>A</given-names></name><name><surname>Theriot</surname><given-names>JA</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group><article-title>Expression and phosphorylation of the Listeria monocytogenes ActA protein
in mammalian cells</article-title><source>Proceedings of the National Academy of Sciences of the United States of
America</source><volume>90</volume><fpage>11890</fpage><lpage>11894</lpage><year>1993</year><pub-id pub-id-type="pmid">8265643</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maile</surname><given-names>R</given-names></name><etal/></person-group><article-title>Antigen-specific modulation of an immune response by in vivo administration
of soluble MHC class I tetramers</article-title><source>Journal of immunology</source><volume>167</volume><fpage>3708</fpage><lpage>3714</lpage><year>2001</year></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorner</surname><given-names>BG</given-names></name><etal/></person-group><article-title>MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with
IFN-gamma as type 1 cytokines</article-title><source>Proc Natl Acad Sci U S A</source><volume>99</volume><fpage>6181</fpage><lpage>6186</lpage><year>2002</year><pub-id pub-id-type="pmid">11972057</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kieper</surname><given-names>WC</given-names></name><name><surname>Prlic</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>CS</given-names></name><name><surname>Mescher</surname><given-names>MF</given-names></name><name><surname>Jameson</surname><given-names>SC</given-names></name></person-group><article-title>Il-12 enhances CD8 T cell homeostatic expansion</article-title><source>Journal of immunology</source><volume>166</volume><fpage>5515</fpage><lpage>5521</lpage><year>2001</year></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>CD5 expression by na&#x000ef;ve CD8<sup>+</sup> T cells identifies stable
populations with unique phenotypic traits</title><p>Flow cytometry of cells combined from spleen and lymph nodes of wild-type
(<bold>a</bold>) or <italic>Il15</italic><sup>&#x02212;/&#x02212;</sup> (<bold>b</bold>)
mice were stained for CD44 and CXCR3 and transcription factors T-bet and Eomes. Data were
gated on naive (CD44<sup>lo</sup> CD122<sup>lo</sup>) CD8<sup>+</sup> T cells in
the lowest 20% (red) and highest 20% (blue) with respect to CD5
expression. Memory phenotype (MP) cells (CD44<sup>hi</sup>CD122<sup>hi</sup>) are
indicated as gray shaded histograms. Data represent expression of indicated molecules and
forward scatter (as a measure of cell size). (<bold>c,d</bold>) Na&#x000ef;ve
CD8<sup>+</sup> T cells were sorted on CD5 expression as indicated and congenic
populations co-transferred into normal recipient mice, which were analyzed 4&#x02013;8
weeks later without immunization. Representative data are shown for the histograms
(<bold>c,d</bold>); <bold>d</bold>, right, summary of compiled data (each symbol
represents an individual mouse). (<bold>e,f</bold>) Flow cytometry of
CD4<sup>+</sup> CD25<sup>&#x02013;</sup> and CD8<sup>+</sup> T cells
from Nur77<sup>gfp</sup> transgenic mice. T cells were gated on the lower or upper CD5
expression and analyzed for GFP expression (<bold>e</bold>). MP cells (gray) are included
for comparison. In (<bold>f</bold>) flow cytometry of HY or OT-I TCR transgenic
CD8<sup>+</sup> T cells, gated on the CD44<sup>lo</sup> population, for CD5 and
Nur77<sup>gfp</sup> expression as compared to polyclonal na&#x000ef;ve
CD8<sup>+</sup> T cells (gray). Data in (a,c,d) are representative of 4
independent experiments (a n=10; c,d n=9), in (b,f) 2 independent
experiments (b n=4; f n=6&#x02013;7) and in (e) 3&#x02013;4 independent
experiments (n=6&#x02013;11).</p></caption><graphic xlink:href="nihms638367f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Na&#x000ef;ve CD5<sup>lo</sup> and CD5<sup>hi</sup> CD8<sup>+</sup> T cells
have distinct gene-expression characteristics</title><p>(<bold>a,b</bold>) Expression of XCL1, CXCR3 and T-bet by na&#x000ef;ve
(CD44<sup>lo</sup>) CD8<sup>+</sup> T cells in the highest 20%
(CD5<sup>hi</sup>) or lowest 20% (CD5<sup>lo</sup>) with respect to CD5
expression and memory phenotype (CD44<sup>hi</sup>) CD8<sup>+</sup> T cell
populations. (<bold>a</bold>) Splenocytes were stimulated with PMA/ionomycin in the
presence of brefeldin A and then stained intracellularly for XCL1. Grey histograms
represent unstimulated cells, solid lines indicate stimulated cells. (<bold>b</bold>)
Frequencies of indicated subsets expressing XCL1, CXCR3 or T-bet. Expression of XCL1 was
determined following activation (as in (a)), while CXCR3 and T-bet expression was
determined in unstimulated B6 or T-bet reporter mice<sup><xref rid="R50" ref-type="bibr">50</xref></sup>. <bold>(c)</bold> CD44<sup>lo</sup> CD8<sup>+</sup> T cells
were flow sorted on the lower/upper 20% of CD5 expression and mRNA from 3
individual sorts was isolated and analyzed using an Affymetrix gene array. Differences
between CD5<sup>lo</sup> and CD5<sup>hi</sup> transcription were compared against gene
clusters associated with stages of the in vivo CD8<sup>+</sup> T cell
response<sup><xref rid="R34" ref-type="bibr">34</xref></sup>. Histograms represent
fold-change ratio for expression in CD5<sup>lo</sup> versus CD5<sup>hi</sup> cells of
genes from clusters II, III and X, revealing preferential expression in the
CD5<sup>hi</sup> population (indicated as a fold change ratio &#x0003c;1). Data in (a) are
representative of 4 experiments (9 mice); data in (b) were compiled from: 4 experiments
(n=9) for XCL1; 3 experiments (n=7) for T-bet; 5 experiments
(n=13) for CXCR3. Data in (c) derive from analysis of gene array analysis from 3
independent cell sorting experiments. * indicates p&#x0003c;0.001</p></caption><graphic xlink:href="nihms638367f2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Na&#x000ef;ve CD5<sup>lo</sup> and CD5<sup>hi</sup> CD8<sup>+</sup> T cell
precursors differ in their capacity to respond to foreign antigen</title><p>CD44<sup>lo</sup> CD8<sup>+</sup> T cells in the lowest or highest 20%
for CD5 expression were sorted and 1.25&#x02013;1.5 &#x000d7; 10<sup>6</sup> each of
congenically distinct CD5<sup>lo</sup> and CD5<sup>hi</sup> cells co-transferred into
CD45.1/CD45.2 host animals, which were infected the next day with LM-B8R.
B8R/K<sup>b</sup>&#x02013;specific cells were isolated from the spleen by
B8R/K<sup>b</sup> tetramer enrichment at the indicated time points. (a) shows the ratio
of donor CD5<sup>hi</sup> and CD5<sup>lo</sup> B8R/K<sup>b</sup>-specific cells at days 7
and 30 after primary LM-B8R infection or 5 days after re-challenge of memory recipients
with virulent LM-B8R, while (b) shows total donor cells number for the d7 timepoint. Each
dot is a host animal. Filled symbols in (a) indicate mice where a
B8R/K<sup>b</sup>-specific response was not detected for CD5<sup>lo</sup> donor cells
&#x02013; the CD5<sup>hi</sup>/CD5<sup>lo</sup> ratio was arbitrarily set to 100. The
double dagger symbol (&#x02021;) indicates an outlier: exclusion of this group did not
alter the statistical significance shown in (b). (c) The ratio of bulk LM-specific donor
CD5<sup>hi</sup>/CD5<sup>lo</sup> CD8<sup>+</sup> T cells from the experiments
shown in (a). Data in (a,c) are shown as the geometric mean &#x000b1; 95%
confidence interval. (d,e) Total CD8<sup>+</sup> CD44<sup>lo</sup> cells were
sorted and combined with congenically distinct CD44<sup>lo</sup> CD5<sup>lo</sup> or
CD44<sup>lo</sup> CD5<sup>hi</sup> populations and 1.25 &#x02013; 1.5 &#x000d7;
10<sup>6</sup> of each population co-transferred into congenic recipients which were
infected with LM-B8R 1d later. The B8R/K<sup>b</sup>-specific (d) and bulk LM-specific (e)
responses were determined 7d after infection. The graphs indicate mean &#x000b1; SEM. (f)
CD5<sup>hi</sup> na&#x000ef;ve CD8<sup>+</sup> T cells (CD44<sup>lo</sup> cells
in the upper 20% for CD5 expression) were sorted into the lowest or highest
30% for CXCR3 expression. 1&#x02013;2&#x000d7;10<sup>6</sup> of congenically
distinct CXCR3<sup>lo</sup> and CXCR3<sup>hi</sup> CD5<sup>hi</sup> cells were
co-transferred into CD45.1/45.2 donors, and infected 1d later with LM-B8R.
B8R/K<sup>b</sup>-specific cells were isolated from the spleen 7d after infection by
tetramer enrichment. The upper panel shows the ratio of cells derived from
CXCR3<sup>hi</sup> versus CXCR3<sup>lo</sup> donor cells in the
B8R/K<sup>b</sup>-specific and bulk LM-B8R responsive populations. The lower panel shows
the number of B8R/K<sup>b</sup>&#x02013;specific CXCR3<sup>hi</sup> and CXCR3<sup>lo</sup>
donor cells isolated. The geometric mean is indicated. (g) Mixed bone marrow chimeras were
generated using congenic wild-type and <italic>Cd25</italic> (IL-2R&#x003b1;)-deficient
bone marrow. Following T cell reconstitution, CD44<sup>lo</sup> CD5<sup>lo</sup> and
CD5<sup>hi</sup> populations were sorted and congenically distinct combinations of WT
and KO cells co-transferred into congenic recipients that were infected with LM-B8R 1d
later. At d7 following infection, the spleen was recovered and the number of
B8R/K<sup>b</sup>&#x02013;specific donor cells enumerated. Data show the geometric mean
&#x000b1; 95% confidence interval. In all figures, each symbol indicates data from
a single animal. Data in (a-c) are compiled from four experiments at day 7 (n =
11), 3 experiments at day 30 (n = 9), and 2 experiments for day 5 recall (n
= 6); (d) shows data compiled from 3 experiments (n = 11&#x02013;12 mice),
(e) from two experiments (n = 8); (f) is compiled from 3 experiments
(n=10); (g) is compiled from 3 individual experiments (n = 6). For this
figure, statistical analysis is indicated as follows: *** for p
&#x0003c; 0.001; ** for p &#x0003c; 0.01; * for p &#x0003c; 0.05.</p></caption><graphic xlink:href="nihms638367f3"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Analysis of clonal na&#x000ef;ve CD5<sup>lo</sup> and CD5<sup>hi</sup>
CD8<sup>+</sup> T cell responses to infection</title><p>The indicated number of sorted CD5<sup>lo</sup> or CD5<sup>hi</sup> cells was transferred
into congenic recipients and the B8R/K<sup>b</sup>-specific donor-derived response was
determined in the spleen 7 days after infection with LM-B8R. (The congenic marker scheme
used is illustrated in <xref rid="SD1" ref-type="supplementary-material">Fig.
S4</xref>).</p><p>(a) Response rate for the indicated number of transferred donor cells for which a
B8R/K<sup>b</sup>-specific response was observed above the limit of detection (5 cells).
Error bars are calculated standard deviation. Statistical analysis using a one-sided
binomial test showed that the response rate for 2.5&#x000d7;10<sup>4</sup> and
1&#x000d7;10<sup>5</sup> CD5<sup>lo</sup> cells (0/40 and 18/125, respectively) were
significantly different from that expected (25% and 100%, respectively)
(p&#x0003c;0.0001 for both) while the response rate for 2.5&#x02013;3.0 &#x000d7;
10<sup>4</sup> CD5<sup>hi</sup> cells was not significantly different from average
expected rate (~27.5%) (p=0.2). (b) Numbers of B8R/K<sup>b</sup>-specific
CD8<sup>+</sup> T cells derived from each donor population, shown as the
geometric mean &#x000b1; 95% confidence interval. Each symbol represents cell
numbers from an individual donor cohort. Donor populations that did not mount a detectable
response are shown on the limit of detection line. Two very large clonal responses are
indicated by arrows. Host responses are shown for comparison. Statistical significance was
assessed only on responses above the limit of detection, using the Mann-Whitney test on
log-transformed values. The numbers of transferred cohorts for each condition is given in
the text, and the data derive from 2&#x02013;4 separate experiments. The symbol *
indicates p&#x0003c;0.05.</p></caption><graphic xlink:href="nihms638367f4"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title>Early recruitment of CD5<sup>lo</sup> and CD5<sup>hi</sup> cells into the immune
response after infection</title><p>(a) Congenically distinct CD44<sup>lo</sup> CD5<sup>lo</sup> and CD5<sup>hi</sup> cells
were sorted and co-transferred into congenic recipients as in <xref rid="F3" ref-type="fig">Fig. 3</xref>. Donor-derived B8R/K<sup>b</sup>-specific responses were
analyzed from the spleen on day 3 or 4 after infection with LM-B8R. Data are shown as the
geometric mean &#x000b1; 95% confidence interval. (b,c) Nur77<sup>gfp</sup>
transgenic mice were injected i.v. with 50 &#x003bc;g anti-CD3 or PBS and spleens
harvested 5 hrs later. Representative data is shown for expression of Nur77<sup>GFP</sup>
and CD69 (b) and CD5 levels (c) on CD44<sup>lo</sup> CD8<sup>+</sup> T cells.
(d-f) Nur77<sup>gfp</sup> transgenic mice were infected with 1 &#x000d7; 10<sup>7</sup>
CFU LM-B8R and spleens harvested 5h later. B8R/K<sup>b</sup>- and
M57/K<sup>b</sup>-specific CD8<sup>+</sup> T cells were isolated by tetramer based
enrichment. (d) Nur77<sup>gfp</sup> and CD69 expression was assessed on B8R/K<sup>b</sup>-
and M57/K<sup>b</sup>-specific CD8<sup>+</sup> T cells, and (e)
B8R/K<sup>b</sup>-specific cells with activated (Nur77<sup>gfp-hi</sup>,
CD69<sup>+</sup>) and non-activated (Nur77<sup>gfp-lo</sup>,
CD69<sup>&#x02212;</sup>) phenotype assessed for CD5 expression. (d,e) are
representative data. (f) shows normalized geometric mean fluorescence intensity (gMFI) for
CD5 expression on non-activated and activated B8R/K<sup>b</sup> specific na&#x000ef;ve
CD8<sup>+</sup> T cells. (a) shows data compiled from a total of 3 experiments
(1 at day 3; n=5, 2 at day 4; n=9); Data in (b,c) are from 2 separate
experiments (n=3); (d&#x02013;f) show representative or compiled data from 3
experiments (n=13) for B8R/K<sup>b</sup>&#x02013;specific cells and 2 experiments
(n=9) for M57/K<sup>b</sup>&#x02013;specific cells. * indicates p &#x0003c;
0.01.</p></caption><graphic xlink:href="nihms638367f5"/></fig><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><title>CD5<sup>hi</sup> and CD5<sup>lo</sup> cells show similar TCR binding to cognate
antigen</title><p>(a) B8R/K<sup>b</sup> and M57/K<sup>b</sup> specific CD8<sup>+</sup> T cells were
enriched from unimmunized mice and CD44<sup>lo</sup> precursors were gated on the lower
and upper 20% of CD5 expression. Tetramer staining intensity (gMFI) was determined
for both groups and expressed as a ratio, to normalize between experiments. (b)
B8R/K<sup>b</sup> tetramer staining (gMFI) and burst size of expanded clonal populations
derived from CD5<sup>lo</sup> and CD5<sup>hi</sup> donor cells at d7 following LM-B8R
infection. Data derive from transfers of 1&#x000d7;10<sup>5</sup> CD5<sup>lo</sup> and
2.5&#x02013;3.0 &#x000d7; 10<sup>4</sup> CD5<sup>hi</sup> cells (see <xref rid="F4" ref-type="fig">Fig. 4</xref>). Tetramer gMFI on donor cells was normalized to tetramer
gMFI on host B8R/K<sup>b</sup>-specific cells from the same mice, to yield relative
fluorescence intensity (RFI). (c) Spleen and lymph node cells from unimmunized mice were
subjected to tetramer enrichment. CD5 expression as gMFI on B8R/K<sup>b</sup>-specific and
M57/K<sup>b</sup>-specific CD44<sup>lo</sup> CD8<sup>+</sup> T cell populations
was compared to normalized CD5 expression on bulk CD44<sup>lo</sup>
CD8<sup>+</sup> T cells. (d) CD5 expression levels on indicated MHC class
I-restricted TCR transgenic CD8<sup>+</sup> T cells. The histograms shows
representative data while the bar graph shows CD5 relative fluorescence intensity (RFI),
CD5 staining on polyclonal B6 CD44<sup>lo</sup> CD8<sup>+</sup> T cells being set
at &#x0201c;100&#x0201d;. (e) MHC class I tetramer binding to TCR transgenic cells after
staining with the indicated range of tetramer concentrations. RFI reflects the geometric
MFI of tetramer staining normalized to maximum intensity, which was set at
&#x0201c;100&#x0201d;. Similar data were obtained in a second experiment. (f) In vitro
activation of TCR transgenic CD8<sup>+</sup> T cells. T cells were incubated with
titrated doses of peptide for 6 hrs and CD69 expression was assessed by flow cytometry.
Data are normalized to maximum CD69 expression. Similar data were obtained in a repeat
experiment. (g) Expression of K<sup>b</sup> or D<sup>b</sup> on RMA-S cells following
incubation with indicated doses of the peptides recognized by studied TCR transgenic T
cells. RFI reflects the MFI of Class I MHC molecule staining, normalized to maximum
intensity, which was set at &#x0201c;100&#x0201d;. Data are representative of three
experiments. (h) OT-I bone marrow chimeras were generated by transferring OT-I bone marrow
(RAG<sup>+</sup>) into irradiated WT or
&#x003b2;2m<sup>&#x02212;/&#x02212;</sup> hosts. Flow plots showing CD5 expression is
representative of 4 separate sets of chimeras. Congenically distinct CD44<sup>lo</sup>
OT-I CD8<sup>+</sup> T cells were enriched from each chimera source and
10<sup>3</sup> cells of each population co-transferred into congenic recipients that
were untreated or infected 1-3d later with attenuated &#x00394;ActA LM-OVA. (i) Donor cell
engraftment (&#x0201c;take&#x0201d;) was determined uninfected recipients, and compared to
ratios of donor-derived populations at 7d and 12d after LM-OVA infection. Data are shown
as mean &#x000b1; SEM.</p><p>In (a) data are compiled from 4 experiments (n = 14 for B8R/K<sup>b</sup>, n
= 9 for M57/K<sup>b</sup>); (b) data are from 18 (CD5<sup>lo</sup>) and 46
(CD5<sup>hi</sup>) clonal responses from at least 3 experiments. * indicates
p&#x0003c;0.05. Statistical significance was not changed by exclusion of the outlier (marked as
&#x02021;); In (c) the data is compiled from 6 experiments (n = 21) for
B8R/K<sup>b</sup>-specific cells and two experiments (n = 8) for
M57/K<sup>b</sup>-specific cells. **p &#x0003c; 0.001. In (d) data are
compiled from 2&#x02013;3 experiments (n=4&#x02013;6); (e,f,g) are representative
of 2&#x02013;3 independent experiments; (h,i) Data are representative or compiled from 4
independent sets of chimeras.</p></caption><graphic xlink:href="nihms638367f6"/></fig><fig id="F7" orientation="portrait" position="float"><label>Figure 7</label><caption><title>CD5<sup>hi</sup> cells preferentially utilize pro-inflammatory signals during
expansion</title><p>Congenically distinct CD44<sup>lo</sup> H-Y and OT-I TCR transgenic
CD8<sup>+</sup> T cells were co-transferred into congenic recipients. Mice were
co-immunized the next day with single peptide-pulsed matured DCs, with or without
collateral infection with &#x00394;actA<sup>&#x02212;/ &#x02212;</sup> LM (a,b) or LCMV
Armstrong (c,d). (a,c) Show total numbers of splenic H-Y and OT-I CD8<sup>+</sup>
T cells 7d post-immunization with antigen pulsed DC, with or without indicated infections,
while (b,d) shows ratios of OT-I/H-Y normalized to the &#x0201c;take&#x0201d; ratio
observed in unimmunized animals 1d after adoptive transfer. All graphs show mean &#x000b1;
SEM. Data in (a,b) are compiled from 3 independent experiments (n=10); data in
(c.d) are compiled from 2 experiments (n=6 for DC alone and n=7 for
DC+LCMV). * = p&#x0003c;0.01; ** = p
&#x0003c;0.001.</p></caption><graphic xlink:href="nihms638367f7"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Major gene expression differences between sorted CD5<sup>hi</sup> and
CD5<sup>lo</sup> na&#x000ef;ve polyclonal CD8<sup>+</sup> T cells</title><p>Gene expression analysis was performed as described in <bold>Methods</bold>, and genes
that showed statistically significant (<italic>P</italic> &#x0003c; 0.05), greater than 2-fold
changes between the populations are indicated. Duplicates result from multiple probe sets
for the same gene.</p></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Gene Symbol</th><th valign="top" align="center" rowspan="1" colspan="1">Fold change</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>UP in CD5<sup>hi</sup></bold></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">A430093F15Rik</td><td align="center" valign="top" rowspan="1" colspan="1">7.16</td><td align="center" valign="top" rowspan="1" colspan="1">0.0170</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">Endod1</td><td align="center" valign="top" rowspan="1" colspan="1">5.79</td><td align="center" valign="top" rowspan="1" colspan="1">0.0233</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">Cxcr3</td><td align="center" valign="top" rowspan="1" colspan="1">5.60</td><td align="center" valign="top" rowspan="1" colspan="1">0.0217</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">A530021J07Rik</td><td align="center" valign="top" rowspan="1" colspan="1">5.48</td><td align="center" valign="top" rowspan="1" colspan="1">0.0033</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">Ly6C1</td><td align="center" valign="top" rowspan="1" colspan="1">5.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.0200</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">Tbx21 (T-bet)</td><td align="center" valign="top" rowspan="1" colspan="1">4.96</td><td align="center" valign="top" rowspan="1" colspan="1">0.0019</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><italic>A530021J07Rik</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>4.74</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>0.0113</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><italic>A530021J07Rik</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>3.66</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>0.0144</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">Ndrg1</td><td align="center" valign="top" rowspan="1" colspan="1">3.42</td><td align="center" valign="top" rowspan="1" colspan="1">0.0224</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">Eomes</td><td align="center" valign="top" rowspan="1" colspan="1">3.41</td><td align="center" valign="top" rowspan="1" colspan="1">0.0255</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">Ighv14&#x02013;2</td><td align="center" valign="top" rowspan="1" colspan="1">3.28</td><td align="center" valign="top" rowspan="1" colspan="1">0.0059</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">Cobll1</td><td align="center" valign="top" rowspan="1" colspan="1">3.11</td><td align="center" valign="top" rowspan="1" colspan="1">0.0033</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">Ms4a4c</td><td align="center" valign="top" rowspan="1" colspan="1">3.08</td><td align="center" valign="top" rowspan="1" colspan="1">0.0172</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">Reck</td><td align="center" valign="top" rowspan="1" colspan="1">3.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.0201</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">Itih5</td><td align="center" valign="top" rowspan="1" colspan="1">3.00</td><td align="center" valign="top" rowspan="1" colspan="1">0.0391</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">Phactr2</td><td align="center" valign="top" rowspan="1" colspan="1">2.97</td><td align="center" valign="top" rowspan="1" colspan="1">0.0431</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">Bcat1</td><td align="center" valign="top" rowspan="1" colspan="1">2.91</td><td align="center" valign="top" rowspan="1" colspan="1">0.0122</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">Cldn10</td><td align="center" valign="top" rowspan="1" colspan="1">2.88</td><td align="center" valign="top" rowspan="1" colspan="1">0.0039</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">9230110F15Rik</td><td align="center" valign="top" rowspan="1" colspan="1">2.85</td><td align="center" valign="top" rowspan="1" colspan="1">0.0293</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">Serf1</td><td align="center" valign="top" rowspan="1" colspan="1">2.76</td><td align="center" valign="top" rowspan="1" colspan="1">0.0314</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">Ptgfrn</td><td align="center" valign="top" rowspan="1" colspan="1">2.72</td><td align="center" valign="top" rowspan="1" colspan="1">0.0458</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">Xcl1</td><td align="center" valign="top" rowspan="1" colspan="1">2.70</td><td align="center" valign="top" rowspan="1" colspan="1">0.0173</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><italic>Eomes</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>2.65</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>0.0361</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">Plac8</td><td align="center" valign="top" rowspan="1" colspan="1">2.60</td><td align="center" valign="top" rowspan="1" colspan="1">0.0137</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">Rrm2</td><td align="center" valign="top" rowspan="1" colspan="1">2.58</td><td align="center" valign="top" rowspan="1" colspan="1">0.0286</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">Fahd1</td><td align="center" valign="top" rowspan="1" colspan="1">2.52</td><td align="center" valign="top" rowspan="1" colspan="1">0.0457</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">Mcart6</td><td align="center" valign="top" rowspan="1" colspan="1">2.43</td><td align="center" valign="top" rowspan="1" colspan="1">0.0019</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><italic>Ms4a4c</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>2.41</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>0.0179</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">Ikzf2 (Helios)</td><td align="center" valign="top" rowspan="1" colspan="1">2.40</td><td align="center" valign="top" rowspan="1" colspan="1">0.0273</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">26</td><td align="center" valign="top" rowspan="1" colspan="1">Xdh</td><td align="center" valign="top" rowspan="1" colspan="1">2.40</td><td align="center" valign="top" rowspan="1" colspan="1">0.0031</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">BB557941</td><td align="center" valign="top" rowspan="1" colspan="1">2.40</td><td align="center" valign="top" rowspan="1" colspan="1">0.0484</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">Cd200</td><td align="center" valign="top" rowspan="1" colspan="1">2.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.0288</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">Anxa2</td><td align="center" valign="top" rowspan="1" colspan="1">2.26</td><td align="center" valign="top" rowspan="1" colspan="1">0.0213</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><italic>Ndrg1</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>2.23</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>0.0047</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">30</td><td align="center" valign="top" rowspan="1" colspan="1">Gsto1</td><td align="center" valign="top" rowspan="1" colspan="1">2.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.0197</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">Cd5</td><td align="center" valign="top" rowspan="1" colspan="1">2.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.0034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">Ptpn4</td><td align="center" valign="top" rowspan="1" colspan="1">2.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.0291</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">Chst11</td><td align="center" valign="top" rowspan="1" colspan="1">2.17</td><td align="center" valign="top" rowspan="1" colspan="1">0.0097</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">Armcx4</td><td align="center" valign="top" rowspan="1" colspan="1">2.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.0115</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">Top2a</td><td align="center" valign="top" rowspan="1" colspan="1">2.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.0321</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">Hopx</td><td align="center" valign="top" rowspan="1" colspan="1">2.14</td><td align="center" valign="top" rowspan="1" colspan="1">0.0143</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><italic>Ndrg1</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>2.12</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>0.0008</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">Il10</td><td align="center" valign="top" rowspan="1" colspan="1">2.10</td><td align="center" valign="top" rowspan="1" colspan="1">0.0249</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">Stmn1</td><td align="center" valign="top" rowspan="1" colspan="1">2.09</td><td align="center" valign="top" rowspan="1" colspan="1">0.0357</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="center" valign="top" rowspan="1" colspan="1">Mrpl35</td><td align="center" valign="top" rowspan="1" colspan="1">2.09</td><td align="center" valign="top" rowspan="1" colspan="1">0.0337</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="center" valign="top" rowspan="1" colspan="1">Lilrb3 &#x00026; Pira</td><td align="center" valign="top" rowspan="1" colspan="1">2.08</td><td align="center" valign="top" rowspan="1" colspan="1">0.0021</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">Coro2a</td><td align="center" valign="top" rowspan="1" colspan="1">2.07</td><td align="center" valign="top" rowspan="1" colspan="1">0.0034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">Cd44</td><td align="center" valign="top" rowspan="1" colspan="1">2.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.0072</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">43</td><td align="center" valign="top" rowspan="1" colspan="1">Kctd15</td><td align="center" valign="top" rowspan="1" colspan="1">2.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.0268</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">Pogk</td><td align="center" valign="top" rowspan="1" colspan="1">2.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.0124</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">45</td><td align="center" valign="top" rowspan="1" colspan="1">Id3</td><td align="center" valign="top" rowspan="1" colspan="1">2.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.0049</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">46</td><td align="center" valign="top" rowspan="1" colspan="1">Pck1</td><td align="center" valign="top" rowspan="1" colspan="1">2.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.0151</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">Aim1</td><td align="center" valign="top" rowspan="1" colspan="1">2.02</td><td align="center" valign="top" rowspan="1" colspan="1">0.0227</td></tr></tbody></table><table frame="box" rules="all"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Gene Symbol</th><th valign="top" align="center" rowspan="1" colspan="1">Fold change</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>DOWN in CD5<sup>hi</sup></bold></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">Dntt</td><td align="center" valign="top" rowspan="1" colspan="1">9.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.0110</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">Slc6a19</td><td align="center" valign="top" rowspan="1" colspan="1">4.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.0025</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"><italic>Slc6a19</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>4.10</italic></td><td align="center" valign="top" rowspan="1" colspan="1"><italic>0.0143</italic></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">Slc16a5</td><td align="center" valign="top" rowspan="1" colspan="1">2.79</td><td align="center" valign="top" rowspan="1" colspan="1">0.0257</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">Ddc</td><td align="center" valign="top" rowspan="1" colspan="1">2.55</td><td align="center" valign="top" rowspan="1" colspan="1">0.0035</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">A130038J17Rik</td><td align="center" valign="top" rowspan="1" colspan="1">2.30</td><td align="center" valign="top" rowspan="1" colspan="1">0.0175</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">Grik4</td><td align="center" valign="top" rowspan="1" colspan="1">2.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.0034</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">Tmem154</td><td align="center" valign="top" rowspan="1" colspan="1">2.10</td><td align="center" valign="top" rowspan="1" colspan="1">0.0322</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">4930513N10Rik</td><td align="center" valign="top" rowspan="1" colspan="1">2.08</td><td align="center" valign="top" rowspan="1" colspan="1">0.0453</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">Tubb2a</td><td align="center" valign="top" rowspan="1" colspan="1">2.03</td><td align="center" valign="top" rowspan="1" colspan="1">0.0200</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">Itk</td><td align="center" valign="top" rowspan="1" colspan="1">2.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.0411</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>TABLE 2</label><caption><p>Alignment between gene set expression differences for CD5hi and CD5lo na&#x000ef;ve
CD8+ T cells, and Immgen gene set clusters for CD8 T cell responses.</p><p>Gene set clusters and designated characteristics are listed (from ref<sup><xref rid="R34" ref-type="bibr">34</xref></sup>). The columns labeled
&#x0201c;CD5<sup>lo</sup>&#x0201d; and &#x0201c;CD5<sup>hi</sup>&#x0201d; indicate the
number of genes from each cluster that were preferentially expressed in that subset. The
column labeled &#x0201c;Proportion&#x0201d; indicates the fraction of those genes
expressed in the CD5<sup>lo</sup> subset. The significance of differential expression was
determined by &#x003c7;<sup>2</sup> test (see <bold>Methods</bold>), and are listed in the
column labeled &#x0201c;P-values&#x0201d;.</p></caption><table frame="box" rules="all"><thead><tr><th valign="top" align="center" rowspan="1" colspan="1">Immgen Cluster</th><th valign="top" align="left" rowspan="1" colspan="1">Characteristics</th><th valign="top" align="left" rowspan="1" colspan="1">CD5<sup>lo</sup></th><th valign="top" align="left" rowspan="1" colspan="1">CD5<sup>hi</sup></th><th valign="top" align="left" rowspan="1" colspan="1">P-value</th><th valign="top" align="left" rowspan="1" colspan="1">Proportion</th></tr></thead><tbody><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster I</td><td align="left" valign="top" rowspan="1" colspan="1">Initial cytokine or effector response</td><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">22</td><td align="left" valign="top" rowspan="1" colspan="1">0.086</td><td align="left" valign="top" rowspan="1" colspan="1">0.352</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster II</td><td align="left" valign="top" rowspan="1" colspan="1">Preparation for cell division</td><td align="left" valign="top" rowspan="1" colspan="1">187</td><td align="left" valign="top" rowspan="1" colspan="1">334</td><td align="left" valign="top" rowspan="1" colspan="1">1.193 E-10</td><td align="left" valign="top" rowspan="1" colspan="1">0.358</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster III</td><td align="left" valign="top" rowspan="1" colspan="1">Cell cycle &#x00026; division</td><td align="left" valign="top" rowspan="1" colspan="1">93</td><td align="left" valign="top" rowspan="1" colspan="1">187</td><td align="left" valign="top" rowspan="1" colspan="1">1.936 E-08</td><td align="left" valign="top" rowspan="1" colspan="1">0.332</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster IV</td><td align="left" valign="top" rowspan="1" colspan="1">Naive and late memory</td><td align="left" valign="top" rowspan="1" colspan="1">51</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">0.248</td><td align="left" valign="top" rowspan="1" colspan="1">0.560</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster V</td><td align="left" valign="top" rowspan="1" colspan="1">Early effector, late memory</td><td align="left" valign="top" rowspan="1" colspan="1">54</td><td align="left" valign="top" rowspan="1" colspan="1">72</td><td align="left" valign="top" rowspan="1" colspan="1">0.108</td><td align="left" valign="top" rowspan="1" colspan="1">0.428</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster VI</td><td align="left" valign="top" rowspan="1" colspan="1">Short-term effector and memory</td><td align="left" valign="top" rowspan="1" colspan="1">27</td><td align="left" valign="top" rowspan="1" colspan="1">37</td><td align="left" valign="top" rowspan="1" colspan="1">0.211</td><td align="left" valign="top" rowspan="1" colspan="1">0.421</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster VII</td><td align="left" valign="top" rowspan="1" colspan="1">Memory precursor</td><td align="left" valign="top" rowspan="1" colspan="1">61</td><td align="left" valign="top" rowspan="1" colspan="1">49</td><td align="left" valign="top" rowspan="1" colspan="1">0.252</td><td align="left" valign="top" rowspan="1" colspan="1">0.554</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster VIII</td><td align="left" valign="top" rowspan="1" colspan="1">Naive or late effector or memory</td><td align="left" valign="top" rowspan="1" colspan="1">129</td><td align="left" valign="top" rowspan="1" colspan="1">138</td><td align="left" valign="top" rowspan="1" colspan="1">0.581</td><td align="left" valign="top" rowspan="1" colspan="1">0.483</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster IX</td><td align="left" valign="top" rowspan="1" colspan="1">Short-term effector or memory</td><td align="left" valign="top" rowspan="1" colspan="1">39</td><td align="left" valign="top" rowspan="1" colspan="1">55</td><td align="left" valign="top" rowspan="1" colspan="1">0.098</td><td align="left" valign="top" rowspan="1" colspan="1">0.414</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">Cluster X</td><td align="left" valign="top" rowspan="1" colspan="1">Late effector or memory</td><td align="left" valign="top" rowspan="1" colspan="1">34</td><td align="left" valign="top" rowspan="1" colspan="1">59</td><td align="left" valign="top" rowspan="1" colspan="1">0.009</td><td align="left" valign="top" rowspan="1" colspan="1">0.365</td></tr></tbody></table></table-wrap></floats-group></article>